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CHAPTER 1 
GENERAL INTRODUCTION 

GENERAL INTRODUCTION 
RHEUMATOID ARTHRITIS 
Rheumatoid arthritis (RA) is a chronic, systemic disease affecting about 1-2% of 
the population. Its aetiology is unknown. The disease is characterized by inflammations 
mainly in the joints and composed of exacerbations and remissions. The susceptibility to 
RA is weakly associated with the human leukocyte antigen (HLA) DR4 (1), indicating a 
genetic predisposition. The disease is more often seen in women than in men (ratio 3:1) 
(2). 
Autoimmunity 
Normally the immune system is able to discriminate between "self" and "non-self" 
(3). As a result, it can respond to an unlimited variety of invading foreign antigens while 
simultaneously it remains nonresponsive or tolerant to its own self-antigens. In 
autoimmune diseases however, the immune tolerance against self antigens is broken. Due 
to this defect autoantibody producing В cells and/or autoreactive Τ cells are able to attack 
self-structures. 
RA is regarded to be an autoimmune disease even though, besides a so called 
rheumatoid factor (RF) no crucial autoreactivity has been demonstrated against a 
particular self antigen. The term RF represents a population of antibodies, which are 
directed against epitopes on the Fc fragment of autologous IgG (4). They form immune 
complexes, which can be detected in rheumatoid synovial fluid and tissue. These 
complexes can fix complement, which points towards involvement in inflammatory 
reactions (5). RF appears to be frequently present in sera of RA patients, although it can 
not be considered as the sole criterion for the diagnosis of RA. 
Regarding the cellular immunity several studies have a -eady shown that Τ cells 
play an important role in RA. One of the first reports on this subject observed that 
removal of Τ cells by thoracic duct drainage lead to an improvement of RA (6). 
Furthermore, reinjection of these removed lymphocytes resulted in a relapse in some 
patients, as did cessation of the thoracic duct drainage in almost all patients. Later studies 
showed that also total lymphoid irradiation (7) and cyclosporin A treatment (8) were able 
to improve RA. Finally, clinical studies are initiated recently to treat RA with the 
chimeric monoclonal anti-CD4 antibodies cM-T412. The first data show that treatment 
with anti-CD4 is associated with a sustained decrease in the number of circulating CD4 + 
T cells. The side effects of anti-CD4 treatment included fever, rigor, chills and 
hypotension, but no serious infectious complications (9). Regarding clinical improvement 
the data are not unequivocal. One study reports no clinical improvement, even though 
histological analysis showed a decrease in the synovial inflammation (10). However, 
another study reported significant improvement in 12 refractory RA patients (11). It was 
shown that antibody dosage and treatment regimen are the crucial factors determining 
clinical outcome. Furthermore, it was observed that the percentage of mAb coated 
lymphocytes in the synovial fluid correlated with the degree of clinical improvement. It 
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was suggested that the amount of anti-CD4 monoclonal antibody entering the RA joint 
may determine clinical efficacy. 
Relationship between RA and bacteria 
Induction of arthritis is likely to be dependent on the concerted action of three 
distinct factors: antigen presenting molecules, an arthritis triggering antigen and antigen 
specific Τ cells. In this molecular triad the antigen plays an important role for as well the 
induction as the maintenance of RA. Unfortunately, up to now the antigen is still 
unknown, although there are several arguments for an involvement of bacteria in the 
pathogenesis of chronic joint inflammation. For instance arthritis has been associated with 
bacterial infections of the throat (acute rheumatic fever) (12), the gastrointestinal or 
urinary tract (Reiter's syndrome, reactive arthritis) (13,14), jejunal bypass surgery for 
obesity, which often results in a bacterial overgrowth (15), inflammatory bowel diseases 
like M. Crohn (16) and Borrelia burgdorferi inducing Lyme disease (17). Furthermore 
several arthritis models exist, which can be induced by the injection of bacteria. 
Since RA is a chronic and systemic disease, it indicates that the antigen must be 
continuously present in either the circulation and/or joint. Combining this with the 
association between bacteria and arthritis one can think of two likely mechanisms, 
explaining this autoimmune disease. First of all a specific Τ cell response against bacterial 
fragments, which may be present in the circulation or persist in the joint. This persistence 
in the joint can for instance be explained by trapping of the antigen in immune complexes 
or by electrostatic interactions of cationic antigens and negatively charged cartilage (18-
20). Another likely hypothesis for the induction and chronicity of arthritis is cross-
reactivity between epitopes on bacteria or viruses and cartilage. 
In reactive arthritis (ReA) the antigens triggering the arthritis are thought to be 
antigens of the microbes that cause the infections of the gut, such as chlamydia, yersinia 
or salmonella (21). Antigens of these bacteria have been indeed detected in synovial cells 
(22-26), and Τ cell specificity for these antigens has been found in the synovium (27-29). 
In RA there are several indications for a direct role of cartilage in the pathogenesis 
of RA. For instance, destructive forms of rheumatoid arthritis tend to decline at the 
moment the cartilage is fully destroyed. Moreover, total joint replacement often results in 
a complete remission of arthritis in that joint. Candidate autoantigens in RA include 
cartilage proteoglycan aggregates, type II collagen and the heat-shock proteins (hsp). 
Regarding the human articular cartilage proteoglycans, Τ cell responses have been found 
in some patients with RA (30,31), but also in healthy subjects (30-32). Furthermore, 
these studies showed no simple relationship between Τ cell responsiveness and disease 
status. This was also the case for other candidate antigens in RA. For example, Τ cells 
responsive to purified type II collagen have been cloned from arthritic joints (33). On the 
one hand, Τ cell responses among patients with RA are generally low (34) and Τ cells 
from healthy individuals are also able to respond to type II collagen (35). Similarly, 
studies on hsp as autoantigen have demonstrated that Τ cell clones from RA inflammatory 
sites can lyse autologous target cells pulsed with hsp60 (36). In addition, it has been 
described that RA synovial Τ cells respond better to members of the hsp60 family than 
peripheral blood Τ cells (37). On the other hand, mycobacterium bovis hsp65 is not 
necessarily an immunodominant Τ cel antigen in RA (38) and cells from joints of some 
adult patients with RA do not respond to human hsp60 (39). All these data suggest that 
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more work is needed to further elucidate, whether reactivity against any of these 
autoantigens has any relevance in the etiopathogenesis of RA. 
ANIMAL MODELS 
Since RA is a complicated autoimmune disease, arthritis models have been 
developed, which closely resemble the human disease. Most of these experimental models 
are developed in rat or mice and can be divided in unilateral or systemically induced 
arthritis models. A well known unilateral model is the antigen-induced arthritis, which 
can be induced by intra-articular injection of antigen into the knee joint of animals 
previously immunized with the same antigen. In contrast to the unilateral arthritis, the 
systemically-induced arthritis models result in a polyarthritis. In general, the polyarthritic 
animal models can be induced in susceptible strains by either structures of the joint itself, 
like collagen-induced arthritis (CIA)(40) and proteoglycan-induced arthritis (41), by 
bacteria, like yersinia-induced arthritis (42), adjuvant arthritis (AA)(43) and streptococcal 
cell wall (SCW)-induced arthritis (44) or by non-immunogenic synthetic oils, like pristane 
arthritis (45) and CP20961 -induced arthritis (46). In addition, there is the spontaneously 
developing MRL-lpr/lpr mouse model (47). Since a more detailed discussion of all the 
animal models goes beyond the scope of this thesis, we will now only focus on CIA, AA, 
SCW-induced arthritis and the CP20961-induced arthritis. 
Collagen-induced arthritis 
Collagen-induced arthritis (CIA) is an experimentally induced autoimmune model 
of chronic erosive arthritis. It can be induced in certain strains of rats (40) and mice (48) 
by intradermal injection of intact ("native") type II collagen, a major component of 
articular cartilage. Both В and Τ cells are crucial for the development of arthritis. The 
importance of antibodies has been demonstrated in experiments in which anti-CII mAb 
can induce a transient arthritis when transferred to healthy animals (49,50) or nude rats 
(51). Evidence that Τ cells play a major role in the development of CIA was obtained 
from observations, that arthritis does not develop in nude (52) or cyclosporin A-treated 
rats (53) and that disease can be adoptively transferred with Τ cell lines or clones (54). 
Furthermore, the development of disease can be prevented with antibodies directed to 
CD4 (55) and TCR (56-58). Regarding the pathogenesis, it is suggested that in the active 
model, binding of anti-CII m Abs to the articular surface may direct the inflammatory 
process towards this tissue. This may explain the extensive cartilage destruction observed 
in CIA. 
Adjuvant arthritis 
Regarding the bacterial-induced arthritis models, most models use either heat-
killed bacteria or bacterial fragments. The oldest and most widely used model is adjuvant 
arthritis (AA). This model is induced by an intradermal administration of heat-killed 
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Mycobacterium tuberculosis (M.tb.) suspended in Freund's incomplete adjuvant 
(FIA)(43). The volume, type of oil, and composition of the emulsion are important 
variables that determine the incidence of arthritis (59,60). Most research on this model 
has been performed in the susceptible Lewis rat and therefore this will be discussed in 
more detail. However, AA can also be induced in certain mice (61). In addition, several 
other studies showed that DA rats injected with FIA alone could develop a mild transient 
arthritis (62,63), while the Lewis strain remained resistant for this type of induction. In 
the Lewis rat the polyarthritis develops within 14 days and subsides again after + 4 
weeks. Interestingly, after this recovery period the Lewis rats are resistant to a renewal 
injection of M.tb. in oil (64). 
In contrast to CIA, AA is primarily a cellular mediated disease. This hypothesis is 
supported by several studies, which have shown that Τ lymphocytes play an important 
role in this arthritis model. For instance, cyclosporin A treatment could prevent the 
development of disease (65). Furthermore, AA could not be induced in nude rats (66), 
and was transferable to naive recipients (67). Finally, treatment with the anti-T-
lymphocyte antibodies anti-CD4 (68) and anti-TCR (69) were able to prevent arthritis. 
Regarding the pathogenesis of this disease, combinations studies on AA and CIA 
resulted in an extraordinarily severe arthritis (70,71). This synergy provides evidence that 
AA and CIA are induced by fundamentally different pathogenic mechanisms. In contrast, 
other studies support the view that at least certain aspects of the pathogenesis of these two 
models may be the same. For instance, anti-СП antiserum suppressed AA (72) and 
transfer of spleen cells of donor rats given СИ/FIA, which themselves did not induce 
disease, could suppress the subsequent arthritic response to AA (73). 
Interestingly, several data suggest that in AA the pathogenesis is an autoimmune 
process, which is triggered by structural mimicry between bacterial antigens and cartilage 
proteoglycans. From studies with the Τ helper clone (A2b) isolated from AA rats, one 
was able to pinpoint a reactivity against the 180-186 epitope of the bacterial 65kD heat 
shock protein (74). Interestingly, this 65kD protein was able to induce an antigen-specific 
suppression of A A (75,76), and a recent study showed that disease could be inhibited by a 
peptide analogue of the 180-188 epitope (77). 
Reports that AA can be adoptively transferred by Τ cells were the first indications 
that crossreactive responses against self-determinants might be involved (67). More recent 
observations confirm the latter hypothesis, since in the adoptive transfer of AA some of 
the donor Τ cells were able to migrate to the synovium (78). Furthermore, the A2b clone 
was able to respond to cartilage proteoglycan and could induce disease in irradiated 
syngeneic recipients (79,80). Finally, in vivo AA could be modulated with fractions of 
proteoglycans (81,82). All these data suggest that crossreactivity between bacterial and 
cartilage antigens is a likely mechanism for the pathogenesis of this disease. On the other 
hand, there are several data, which indicate that during the initiation of A A also other 
mechanisms may play a role. For instance, arthritis can be induced with the non-
immunogenic oil CP20961 and this disease is indistinguishable from the classical A A 
(46). Furthermore, even more surprising are the data that lymphocytes from these 
CP20961 treated rats recognized the bacterial antigen M.tb. (83). These data suggest that 
the oil may also induce a second mechanism, which can be described as a nonspecific 
immunomodulation resulting in expression of normally suppressed autoimmunity. 
Inbred rat strains have been found to differ in their susceptibility to AA, indicating 
that genetic factors control the susceptibility to AA. For example, Lewis rats are highly 
susceptible to AA, while F344 (Fisher) rats, despite the fact that they share the same 
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RTl.B and RTl.D МНС class II loci with Lewis, are not susceptible to AA (84). 
Interestingly, F344 rats kept and bred under germ-free conditions are susceptible to AA 
(85), whereas colonization of the germ-free rats with gram-negative bacteria again 
suppressed the disease susceptibility (86). The relevance of these findings are discussed 
below. 
Streptococcal cell wall-induced arthritis 
Another important bacterial arthritis model is the streptococcal cell wall (SCW)-
induced arthritis. It can be induced by an intraperitoneal injection of a sterile, aqueous 
suspension of bacterial cells or cell wall fragments from group A streptococci (44). In 
addition, a similar disease can be induced with cell wall fragments of other bacteria, such 
as Lactobacillus casei or Eubacterium aerofaciens (87,88). The latter gram-positive 
bacteria are the major residents of the human intestinal flora. This indicates that large 
amounts of potentially arthritogenic stimuli are continuously present in the gastrointestinal 
tract. 
Injection of this poorly biodegradable material results in an acute systemic illness 
together with swelling and redness of the joints. This acute disease occurs after 1 day, 
wanes after 4-7 days and is dependent on activation of the alternative pathway of 
complement (89). Acute disease is inducible in all rat strains and in nude or 
thymectomized rats, indicating independence of functional Τ cells. The acute phase is 
followed by a chronic, erosive polyarthritis, which mainly involves peripheral joints. In 
contrast with the acute phase, the chronic joint inflammation only develops in a limited 
number of rats strains, namely Lewis and Sprague Dawley rats (90,91). 
In the SCW-induced arthritis persistance of the poorly degradable fragments is of 
utmost importance for chronicity, since administration of mutanolysin (a muralytic 
enzyme which effectively degrades SCW) after injection of the cell walls, resulted in 
prevention of this chronic joint disease (92). In addition, when chronic inflammation has 
subsided, arthritis can be reactivated by systemic challenge with homologous or 
heterologous cell walls or with bacterial lipopolysaccharide (LPS)(93,94). Due to these 
latter observations the SCW-induced arthritis significantly differs from AA. In line with 
the previously described models the chronic phase of the SCW-induced arthritis is also Τ 
cell dependent. Arthritis could not be induced in athymic (nude) Lewis rats (95) and 
cyclosporin A was able to effectively inhibit the chronic phase in euthymic Lewis rats 
(96). Furthermore, a SCW specific Τ cell line was able to induce arthritis in naive 
syngeneic recipients (97) and the development of disease could be prevented by treating 
the animals with antibodies directed against CD4 (98) or the TCR (99). 
The susceptibility to this form of arthritis is still not completely understood. As in 
AA, also in the SCW-induced arthritis F344 rats are resistant when compared to Lewis 
rats (100). This suggests that susceptibility is not dependent on the MHC genes alone. 
Furthermore, several other studies showed that susceptibility could not be explained by 
persistence of the antigen, since in the body and joints this was comparable in both 
strains. However, due to the importance of Τ cells in the chronic phase, this difference 
may be explained at the level of Τ cell immunity. Regarding to this it was shown that the 
susceptible Lewis rats were able to mount a marked SCW-specific Τ cell response against 
SCW material after various immunization protocols, while the F344 rats were totally 
unable to do so (101). This unresponsiveness of the F344 rats was not due to a general 
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defect of the immune system, since control studies with other antigens showed that the 
F344 rats were capable of mounting distinct Τ cell repsonses. In addition, it was shown 
that depletion of Τ suppressor cells in vitro resulted in a restoration of the Τ cell 
response. This demonstrated that active suppression can play an important role in the 
F344 strain. Of course the immune system of resistant F344 rats will have a good reason 
not to respond to the SCW material. Again a likely explanation might be the existence of 
crossreactivity between bacterial epitopes and cartilage proteoglycans. Along this line, the 
F344 strain simply recognizes the danger of responding to these potential cross-reactive 
epitopes and as a result the F344 strain remains resistant to SCW-induced arthritis. 
There are several mechanisms supposed to be involved in self-tolerance and thus 
may be indirectly responsible for the resistance of the F344 strain. First of all there is a 
mechanism, which operates at the level of Τ cell development and called clonal deletion. 
In this process Τ cells, which express the aß Τ cell receptor with specificity for peptides 
derived from self structures will be deleted from the repertoire (102). This deletion or 
programmed cell death is better known as apoptosis. In addition, mechanisms of 
peripheral tolerance exist and both clonal anergy (103) and active suppression have been 
postulated to fulfill this role. Regarding the mechanism of anergy, mature self-reactive Τ 
cells recognize their specific antigen in the periphery and instead of being activated, these 
cells become functionally inactivated. This process of clonal anergy appears to be 
correlated to the inability to produce IL-2 (104). Finally, self-tolerance can be maintained 
by active suppression (105). In this process Τ cells with a specificity for suppression 
inducing epitopes can inhibit the response of Τ cells to self-antigens. 
Several studies have investigated, whether this tolerance against bacterial 
fragments is acquired early in life through contact with bacteria of the gut flora. 
Therefore the susceptibility of the germ-free F344 strain was analysed and it was 
observed that these rats were susceptible to SCW-induced arthritis and were also able to 
mount a SCW specific Τ cell response (106). These data in germ-free animals, together 
with similar findings in AA suggest that the gut flora plays a important role in the 
induction and maintenance of immunological tolerance to bacterial antigens. However, 
whether this tolerance against bacterial antigens can be considered as crosstolerance 
against cartilage fragments is tempting to suggest but remains to be further investigated. 
THE NEUROENDOCRINE SYSTEM 
Apart from immunological tolerance, recent studies found increasing evidence of 
interactions of the central nervous system (CNS), the neuroendocrine system and the 
immune system. In these systems the hypothalamus-pituitary-adrenal (ΗΡΑ) axis is an 
important loop, which is able to connect joint inflammation with the brain. 
Inflammatory stimuli such as bacterial fragments are able to dramatically increase 
the production of interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-a) (107,108). 
Both non-specific proinflammatory cytokines are predominantly produced by macrophages 
and possess a wide variety of biological activities, of which the activation of the ΗΡΑ 
axis is an important one (109,110). Although the precise site of action is unknown, they 
either directly or indirectly act at the level of the hypothalamus to release corticotropin-
releasing factor (CRF) and arginine vasopressin (AVP)(111,112). These neurohormones 
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are both secreted into the hypophysial portal system and play major and synergistic roles 
in the regulation of pituitary ACTH secretion, which in turn stimulates the production of 
glucocorticoids by the adrenal cortex. Along this line the ΗΡΑ axis can exert a negative 
feedback on the immune system, and thus may be an important mechanism in the 
modulation of joint inflammation. How important this may be, can be illustrated by the 
findings of Sternberg et al. (113). They were able to show that the Lewis rat, which is 
susceptible for several other autoimmune diseases, has a defect in its ability to 
biosynthesize CRH in the hypothalamus (114). As a result the Lewis rat was unable to 
significantly increase its corticosteroid levels when a stressful situation, like the injection 
of SCW material, was induced. In addition, they showed that the F344 strain could 
produce high corticosteroid levels to the same stimulus and that these rats became 
susceptible for SCW-induced arthritis when they were treated with the glucocorticoid 
receptor antagonist RU 486. From these data it was postulated that the production of high 
levels of corticosterone is a mechanism of the F344 strain to protect itself from disease 
development. However, this hypothesis is not in agreement with the observation that the 
germ-free (GF) F344 rats are susceptible. In contrast to the low CRH production in the 
Lewis rats, the same rats appear to have an increased AVP production, which probably 
serves as a mechanism to compensate for insufficient CRH and glucocorticoid secretion 
(115). 
In contrast with the indirect systemic immunosuppressive effects of CRH, a recent 
study reported that locally produced CRH can exert proinflammatory effects, since anti-
CRH treatment could suppress a locally induced inflammation (116). Similarly, local 
proinflammatory effects may explain the observation that the CRH protein was expressed 
at high levels in the inflamed joints of Lewis rats and virtually absent in the F344 rat 
joints (117). Furthermore, these data illustrate the complex interrelationships of the 
nervous, endocrine, immune and inflammatory systems. 
Interestingly, a similar impaired glucocorticoid response has been described for the 
Obese strain of chickens (118). In addition, it was shown in experimental allergic 
encephalomyelitis (EAE), an autoimmune disease model for the central nervous system 
(CNS), that the resistant PVG rats produce higher levels of corticosterone to ether stress 
than susceptible Lewis rats (119). During this inflammatory process, which normally lasts 
5-7 days, an increase in corticosterone appeared to be essential for the recovery phase of 
this disease, as has been demonstrated after adrenalectomy in Lewis rats (120). 
Furthermore, adrenalectomized PVG rats became highly susceptible to EAE and steroid 
replacement therapy was able prevent the fatal outcome of this disease. These data again 
indicate that the endogenous production of glucocorticoids plays an important role in the 
regulation of inflammatory processes, like in experimental autoimmune diseases. 
Recently, it has been demonstrated that also patients with RA have a defective 
hypothalamic response to immune and inflammatory stimuli. This was showed in a 
decreased ACTH/cortisol and increased prolactin production during stress (121,122). Both 
Cortisol and prolactin are hormones which can exert its effects on the immune system, 
although prolactin augments immune reactivity instead of suppressing it (123). These data 
again indicate the relationships between the neuroendocrine and immune system. Future 
research will further elucidate the relevance of the neuroendocrine system in RA and 
bacterial arthritis models. 
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AIM OF THE STUDY 
In this thesis we explored mechanisms underlying the regulation of susceptibility to 
bacterial-induced arthritis in various rat strains. The observation that Τ lymphocytes play 
an important role in these models is taken as a starting point of this research. 
In chapter 2 we investigated the involvement of the CD4+ cells in the induction 
and maintenance of the SCW-induced arthritis. Therefore CD4+ cells were depleted 
before the onset of arthritis or in an established disease. In addition, we performed long-
term studies to examine mechanisms of resistance to bacterial-induced arthritis. 
In chapter 3 we studied the relevance of the in vitro cross-reactive responses 
between bacterial epitopes and cartilage in the pathogenesis of bacterial-induced arthritis. 
Therefore we performed a histological analysis in different arthritis models and compared 
the level of proteoglycan depletion at different timepoints after arthritis induction. 
Moreover we examined, whether the release of proteoglycan fragments in the synovial 
fluid was able to elicit an inflammation in Lewis rats, which were previously immunized 
with SCW/FIA. 
In chapter 4 the pathogenesis of bacterial-induced arthritis was further analysed, 
by performing adoptive transfer experiments. In this study it was tested, whether donor Τ 
lymphocytes are capable of specific migration to the joints and subsequently initiate 
arthritis. These experiments may give indirect evidence, on whether antigen specific Τ 
lymphocytes are able to recognize defined antigens in the joint. 
Next, we examined the contributing role of the neuroendocrine system in 
determining the susceptibility to bacterial-induced arthritis. We focused in chapter 5 on 
active suppression and/or adrenal activity as determinants regulating the resistance against 
adjuvant arthritis in the Fisher rat. In chapter 6 both systems were further investigated. 
Using different Wistar lines and both conventional and germfree rats, we analysed the 
relative importance of the adrenal activity and bacterial flora in determining the 
susceptibility to bacterial-induced arthritis. 
Finally, in chapter 7 it was investigated, whether adjuvant arthritis could be 
suppressed by blocking the influx of inflammatory cells with antibodies against adhesion 
molecules. 
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CHAPTER 2 
Treatment of rats with monoclonal anti-CD4 induces long-term 
resistance to streptococcal cell wall-induced arthritis 
Eur. J. Immunol. 22: 57-61, 1992. 
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Treatment of rats with monoclonal anti-CD4 
induces long-term resistance to streptococcal cell 
wall-induced arthritis 
To investigate the role of CD4' cells in the induction and maintenance of 
streptococcal cell wall (SCW)-induced arthritis. Lewis rats were treated with a 
monoclonal antibody against rat CD4 (W3/25) Injection before onset of the 
arthritis resulted in resistance to SCW arthritis. Treatment with anti-CD4 during 
ongoing arthritis induced an amelioration of the arthritis, demonstrating that 
CD4μ cells arc involved in both the induction and effector phases of the chronic 
arthritis. 
After return of CD4+ cells to normal levels in the circulation, no arthritis 
occurred in protected rats, despite the continued presence of SCW in the body. 
Even reinjection of SCW could not induce arthritis in these rats, suggesting that 
tolerance to SCW had occurred In addition, these tolenzed rats were refractory 
to actively induced adjuvant arthritis (ΑΛ), but were susceptible to passively 
transferred AA 
Our data imply, that (a) treatment with anti-CD4 plus SCW induces a long-term 
resistance to SCW-induced arthritis and adjuvant arthritis, (b) SCW and 
M tuberculosa may use similar mechanisms of regulation of arthritis and (c) 
active peripheral suppression is not the mechanism of this nonresponsiveness. 
1 Introduction 
Τ lymphocytes are considered to have an important role in 
the pathogenesis of rheumatoid arthritis (RA) and many 
animal models which resemble various aspects of this 
human disease. Models for chronic polyarthritis are used, 
because it is more convenient to study the involvement of 
Τ lymphocytes in initiation and maintenance of arthritis 
this way. For some of these models, e.g. adjuvant arthritis 
(AA), collagen type Il-induced arthritis and streptococcal 
cell wall (SCW)-induced arthritis, the dependence upon 
Tcells has been shown in studies in nude (alhymic) rodents 
[1.2] and by transferring the disease to naive recipients 
with Tcell lines [3-6] or clones [7, 8]. Another approach to 
study the role of Γ lymphocytes is by in vivo depletion using 
(monoclonal) antibodies directed against cell surface deter­
minants on Tcells while attempting to induce arthritis. 
Experiments have been done using prophylactic protocols 
in collagen type Il-induced arthritis [9]. in AA [10, 11] and 
in murine lupus [12] Patients with RA are also reported to 
benefit from treatment with anti-CD4 mAb [13]. In 
addition, we showed that exacerbations, which may be 
responsible for chronicityof SCW-induccd arthritis are fully 
dependent on CD4* Tcells [14]. Here we report the use of 
mAb against rat CD4 (W3/25) in SCW-induced arthritis. 
This chronic, erosive polyarthritis is induced in susceptible 
Lewis rats by one i.p injection of a sterile, aqueous 
suspension of cell walls from Streptococcus pyogenes. 
Prerequisites for chronic disease arc persistence ot the 
poorly biodegradable cell walls [15. 16| and functional 
[I 9817] 
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Abbreviations: SCW: Streptococcal cell wall AA: Adjuvant 
arthritis RA: Rheumatoid arthritis aBSA: Amidaicd BSA 
Tlymphocytes|l,2.14. 17-19] that are specific for SCW. To 
investigate the involvement of CD4 ' cells in the disease, we 
depleted CD4' cells before onset of arthritis or in estab­
lished disease. Additionally, we performed long-term stu­
dies to elucidate the mechanism of (prolonged) resistance 
to arthritis. 
2 Materials and methods 
2.1 Rats 
Female Lewis rats were originally obtained from the 
Zentral Institut fur Versuchsticrzucht (Hannover. FRG) 
and were bred in our own facilities. Rats weighed 125-150 g 
at the start of the experiments. 
2.2 SCW 
Streptococcus pyogenesTYl organisms were cultured over­
night in Todd-Hewitt broth Cell walls were prepared as 
described [1, 20]. The resulting 10000 χ g pellet was used 
throughout the m vivo experiments, while the 100(XX) χ g 
pellet was used in vitro. These preparations contained 11% 
muramic acid [21] Bacteria were kindly provided by Dr. 
Maarten Hazenberg, Erasmus University, Rotterdam, The 
Netherlands. 
2.3 Induction of SCW arthritis 
To induce a chronic polyarthritis, rats were injected) ρ with 
a sterile, aqueous suspension of SCW in a dose of 15 μg 
muramic acid/gram rat body weight. Arthritis was scored 
macroscopicallv by measuring hindpaw thickness with a 
caliper, and by histology. The increase of paw thickness 
during the longest experiment (150 days) due to growth of 
rats never exceeded 1 mm. 
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2.4 Induction of AA Table 1. Histological score of SCW induced arthritis·" 
I ewis rats were injected intracutaneous!) at the base of the 
tail with 1 mg heat killed M\cohacwrium tuberculous 
organism (H37Ra Difco Laboratories Ine , Detroit MI) 
suspended but not emulsified in oil [22] 
2.5 Passive transfer of A A 
Lewis rats were injected with M tuben ulosis suspended in 
oil in four footpads and at the base of the tail 
(125 μρΛΟ μΐ/injection site) Ten days later draining I N 
were removed cells were further purified and actuated in 
\ uro as described [4] Cells were collected and 5 x 10s cells 
were in|ected ι ν into recipient rats 
2.6 Treatment οΓ rats with mAb 
Rats were injected ι ρ with 4 mg mouse mAb at days 0 and 
3 or at days 13 16 and 19 after arthritis induction The 
experimental group received W3/25 (mouse IgC«i anti rat 
CD4) whereas the control group received BOM22 (mouse 
lgG| anti human CD74 kindly provided by Dr Wil A 
Allcbcs University Transfusion Service Transplantation 
Serology [23]) 
2.7 Histology of ankle joints 
Ankle joints were removed and processed for histology as 
described [24] Seven micrometer paraffin sections were 
made and stained with hematoxilin and eosin 
2.8 Immunofluorescence 
One million splemcTcclls (see above) were incubated with 
10 ng/ml W3/25 or with BOM22 (contiol) in PBS supple­
mented with 0 1% BSA and 0 01% NaN, Alter 30 mm on 
ice cells were washed twice and incubated with 1/50 diluted 
FITC-goat anti mouse IgGi (Nordic Tilburg The Nether 
lands) Alter 30 mm on ice cells were washed thrice and 
fluorescence was scored 
2.9 DTH reaction 
Rats were immunized with amidatcd BSA (aBSA [25]) 
emulsified in IFA (ΙΟΟμμ aBSA in each forepaw) and 
boosted with 2 χ UK) μg aBSA/Ii A in the flanks I week 
thereafter At da\ 15 10 μρβΒΒΑΊΟ μΙ PBS were injected 
into the pinna of the right ear After 24 and 48 h the DI H 
reaction was measured 
3 Results 
3.1 Effect of treatment with anti-CD4 on development, 
of SCVV-induced arthritis 
Rats were injected ι ρ on days 0 and 3 with 4 mg W3/25 
(anti CD4) or BOM22 (control) Due to this treatment 
<2Do W3/25* cells were detectable in a suspension of 
a) Histological score at day 19 aller the last SCW injection (ι с 
dav 19 or dav 102) Infiltrate and exudate was scored using a 
scale from 0-3 by two indi pendent observers (Mf-vdB MC Jv B) 
on coded hcmatoxvlin and cosin stained sections 0 no 
infiltiatc/exudate 3 — large mass of infiliralc/exudate 
splenic Τ cells at day 4 while at day 19 the percentage of 
W3/25* cells was 59% and 62% in the W3/25 group and the 
BOM22 group respectively (immunofluorescence data 
not shown) An arthntogenic dose of SCW was given on 
davO 
Treatment with W3/25 in a phrophylactic protocol resulted 
in virtual absence of SCW induced arthritis (Fig 1) while 
the control group followed the normal course of arthritis 
This dilference was also confirmed by histology (Table 1) 
To investigate the effect of anti CD4 in the established 
disease we injected mAb on days 13 16 and 19 W3/25 
induced a decrease of the paw swelling when compared to 
the control group (/>-0 008 on day 23 and on day 30 
Wilcoxon rank test) However histological analysis showed 
ARTHRITIS SCORE 
220-
200 
160-
140 
120 
100 
00 
0 10 30 SO 70 80 110 130 
DAYS 
Ьіцші I Rats were injected with 4 mg mAb (WV2S anti CD4 
BOM22 subclass conimi) at davs 0 and 3 An arlhnlogemc dose 
ol SC W was given at davs 0 and 83 Arthritis score is expressed as 
the sum of thickness of both hmdpaws (xO 1 mm) Each group 
consisted of 12 rats 
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little difference between rats treated from day Π on with AHTHRITIS SCORE 
WV25 or with BOM22 (Table 1) 
3.2 Long-term effect of treatment with anti-CD4 on 
SCW-induced arthritis 
Rats were injected on days 0 and 3 with 4 mg W3/2S or with 
BOM22 (control) SCW arthritis was induced on dav 0 in 
both groups Fven when the level of W3/2V lymphocytes 
had returned to normal (day 19 and later data not shown), 
no arthritis occurred in this group, whereas the stimulus 
(SCW) was presumably still present in the animals (16. 26| 
To determine whether the newly formed CD41 cells were 
refractory to SCW or whether the amount of SCW left in 
the rats was too low we reinjected rats from both groups 
with an arthnlogenic dose of cell walls (F-ig 1) or with one 
third thereof (= subarthnlogenic dose) on day 84 The 
W3/25 treated group remained resistant to SCW induced 
arthritis, whereas the control group developed a polyarthri­
tis upon reinjeclion with SCW with a' normal" seventy but 
with an accelerated onset (1 day after injection is the 
normal onset on day 12) Paw swellings in rats I hat received 
one third of the arthntogenic dose of cell walls were similar 
to those shown in Tig 1 (data not shown) Thus rats that 
had developed an SCW-induced arthritis and subsequently 
recovered displayed an enhanced susceptibility to a further 
SCW induced arthritis both with respect to SCW dose and 
to dav of onset (BOM22-treatcd group) In contrast, rats 
that are made resistant to SCW-induced arthritis by 
depletion of CD4 ' cells plus SC W remained resistant to a 
further challenge, even after full recovery of CD4' cells 
(W3/25-treated group) 
Histological analysis confirmed the macroscopically 
obtained results (Table 1) Injection with rats with anti-
CD4 alone on days 0 and 3 followed by an injection with 
SC Won dav 82 does not lead to resistance to SCW-induced 
arthritis (mean paw thickness on day 20 after SCW W3/2S 
- 169 ± 12, BOM22- 173 ± 15) 
3.3 Λ Λ in rats with a long-term resistance to 
SCW-induced arthritis 
The above data suggest that injection of anti-CD4 together 
with an arthntogenic stimulus (SCW) results in a long-
lasting resistance to arthritis induced by this stimulus To 
investigate whether these rats were also resistant to arthritis 
induced by another stimulus we induced AA. or we 
passively transferred AA at day 62 (Fig 2) I he group 
which received a control mAb and SCW displayed an 
accelerated onset ot arthritis upon M tuberculosa admin-
180 
170 
150 
130-
110 
90 
V-V ' s ^ 
10 IS 20 25 30 35 40 
DAYS 
ficuii' 2 Rats were injected wilh 4 nig mAb (W3/2S" = anti CD4) 
( · ) or BOM22 (subclass control) (A) at davs 0 and 1 and an 
arthnlogenic dose of SCW at dav 0 Al da\ 62 (—davO in this 
ligure) rais were injected wilh 1 mg V/ tuberculosis in oil (АЛ) 
(ÒA) or with V/ rn/TíTcií/oí/T-specific Tcells (passive transfer of 
AA) (Ο Δ) Arlhnus score is expressed as the sum of thickness of 
both hindpaws (xfl I mm) Each group consisted of three rats 
istration similar to that seen after reinjection of SCW in 
this group thus providing evidence foi crosspnming W3/25 
and SCW-trealed rats were refractory to A A I his data 
strongly suggests that despite the fact that AA and 
SCW induced arthritis were induced by different stimuli 
the (auto)antigen which is recognized in m o may be the 
same Passively transferred AA, however is inducible to a 
comparable extent in "tolerant' (anti-CD4-treated) and 
"non-tolerant" (BOM22-treated) rats, excluding active 
suppression of arthntogenic cells in the periphery as the 
mechanism of this tolerance Proliferative responses 
against SCW, M tuberculosis or the б кІіа heat-shock 
protein were present in the BOM22-treated group (slimu 
lation induces 25. 14and 10 respectively), but absent in the 
anti-CD4-treated group (stimulation induces 5, 2 and 2 
respectively) stressing the relation between arthritis and 
specific Τ cell responses 
3.4 Specificity of SCW plus anti-CD4-induced tolerance 
To investigate whether the observed immunological non-
rcsponsivcness was for bacterial (arthnlogenic) antigens 
only,we immunized rats which received mAb at days 0 and 
table 2 Influence of treatment wilh SCW and І/З^ or BOM22 on Ihe induction of DIII reactions in the car'1 
Treatment 
SCW mAb 
Day 0 W3/35, Days 0 and 3 
Day 0 BOM21, Days 0 and 3 
aBSA 
pnming 
Day 80 
Day 80 
DTH"» 
R/L ratio of ear thickness1·' 
24 h 48 h 
151 ± 0 03 
153 ± 0 02 
102 ± 0 01 
1 6 1 ± 0 0 2 
1 54 ± 0 02 
101 ± 0 02 
a) The \alues represent the mean ± SD from groups 
of four rats 
b) A DTH reaction waschcitedrn injection of 10 μg 
aBSA in the right ear of rats The left car was 
injected with PBS 
c) Values are obtained b\ dmdinglhc measured car 
thickness of the right (R) b\ the left (L) 
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3 and SCW at day 0 at day 80 with aBSA and tested for 
cell mediated immunity m wio IS days after immunizj 
tion The response to aBSA as measured by a DTH 
reaction was similar in rats which were injected with SCW 
plus ami С D4 (tolerant) and in rats injected with BOM22 
plus SCW (responsive) (lable 2) suggesting that the 
nonresponsivencss resulting in resistance to SCW arthritis 
and A A is not a nonspecific phenomenon 
4 Discussion 
There is considerable evidence suggesting a role for 
Г lymphocytes in the pathogenesis of polyarthritis induced 
by SCWor mycobacteria in oil (AA) in the rat [1-5 7 14 
17 18 27] Furthermore the induction of resistance to 
bacterium induced arthritis by low dose tolerance due to 
administration of the 65 kDa bacterial common antigen 
(heat shock protein) [18 28] or cell wall preparations 
(unpublished observations) stress the importance of (spe 
cific) Tcclls For AA use ot anti CD4 antibodies has 
demonstrated the dependence of the model on CD4+ cells 
[11] 
Here wc present evidence that С D4* cells (predominantly 
f h lvmphocytes) are essential for the induction of SCW 
induced arthritis and are highly involved in the effector 
phase In CD4 depleted rats SCW induced arthritis was 
not inducible Treatment which started in an ongoing 
arthritis (day 13) induced a significant remission Interest 
ingly in rats treated in a prophylactic protocol no arthritis 
occurred after day 19 whereas at that limepoint CD44 cells 
had returned to normal level and a large amount of SC W 
was still present in tissues and circulation [14 16 26 29 
30] One explanation might be the possibility that SCW 
were unaccessible for the immune system (due to seques 
lering in phagocytes for instance) Consequently rats were 
reinjected with an arthntogcnic dose of SC W or with one 
third thereof (nonarthntogenic in naive Lewis rats) at 
day 84 I he subclass control group developed an arthritis 
with an accelerated onset and a severity comparable to the 
first SCW induced arthritis In addition the arthntogcnic 
and the subarthntogenic dose of SCW induced a similar 
arthritis Thus a previous SCW induced arthritis primes for 
a subsequent SCW induced arthritis rather than protects 
which is the ease with AA [28] Rats which received 
anti CD4 mAb together with SCW however were com 
pletely resistant to further attempts to induce SC W arthn 
tis suggesting a state ot tolerance to SCW This is similar to 
the situation in AA [11] where anti CD4 treatment plus 
mycobacteria both prevented the induction of arthritis and 
rendered the rats resistant to renewed induction of the 
disease 
To investigate the mechanism of this tolerance we induced 
A A and we passively transferred A A 62 days after injection 
with SC W and mAb Subclass control treated rats devel­
oped both the active and the passive AA with the former 
displiving an accelerated onset Anti CD4 treated rats 
were resistant to active AA but developed the passively 
transferred form Thus the state ot tolerance is not 
maintained by active peripheral suppression but by a 
mechanism which acts earlier inTcell development (possi­
bly in the thymus) 
That pretreatment with anti CD4 at the time of priming 
with SCW induces resistance to SCWarthntis and AA and 
at the lime of priming with M tuberculosis induces resis 
tance to AA and to arthritis induced by the non antigenic 
synthetic adjuvant CP20961 [31] (unpublished observa 
tions) suggests that in all three models the same (auto)an 
tigens are involved 
The mechanism by which anti CD4 together with SCW 
induces specific nonresponsiveness mav be similar to 
tolerance induction to human gamma globulin (HGG) in 
mice [32] administration of HGG together with anti L 3T4 
induced a state of HGG specific tolerance which did not 
involve С D8+ cells This may be explained as follows 
131-35] Tcells that are stimulated by antigen (signal 1) 
only become responsive if they also receive signal 2 
otherwise they arc tolcnzed Signal 2 can consist of a signal 
provided by the APC as a result of cross linking events of 
surface receptors Removal of CD4h cells or functional 
blocking of С D4 may result in a weaker contact between 
MHC antigen complex on the APC and the TcR/CD4 
complex on the Tcell thus interfering with the second 
signal |32 36] For this tolerance to be everlasting the 
tolerogen has to be present continuously [32] In this 
context one can imagine that the presence of certain 
(auto)antigens which are relevant for arthritis may be 
auxiliary in the maintenance of tolerance 
Considering the Lewis rat and its enhanced susceptibility to 
autoimmune diseases in general and more specifically to 
bacterium/adjuvant induced arlhritides it is possible that 
in Lewis rats the natural state of tolerance to auloantigens 
is a delicate balance which is more easily disturbed than in 
other rat strains When the immune system ot 1 cwis rats is 
strongly stimulated with bacterial and synthetic adjuvants 
this stale of tolerance can be broken Control of the already 
existing autoreactive repertoire is lost and chronic poly 
arthritis results The specificity of the existing but normally 
controlled repertoire may determine the organ specificity 
of the disease When rats are treated with anti CD4 at the 
same time that tolerance is broken the cells to be activated 
miss a second signal and become tolerant as long as the 
stimulus remains present It the stimulus is an autoantigen 
breaking of tolerance by nonspecific mechanisms together 
with anti CD4 may induce permanent protection in indi 
viduals susceptible to autoreactivity 
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CHAPTER 3 
Cross-reactivity to proteoglycans in bacterial arthritis: lack of 
evidence for in vivo role in induction of disease 
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Cross-Reactivity to Proteoglycans in Bacterial Arthritis: Lack of 
Evidence for in Vivo Role in Induction of Disease 
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W В VAN DEN BbRG 
Department of Rheumatology University Hohpital Nijmegen PO Box 9101 6500 HB Nijmegen The Netherlands and'Connective Tissue 
Disease Research Lilly Research Centre V/indlesham Surrey United Kingdom 
Cross-reactivity between bacterial epitopes and tartilage 
components has been assumed to play a role in the pathol­
ogy of bacterial-induced arthritis models In this study, we 
report prominent proteoglycan (PG) depletion in Safranin-0 
stained ankle joint sections from collagen-induced arthritic 
rats. In adjuvant arthritis and streptococcal cell wall-
induced arthritis (SCW-A), however, only limited PG deg­
radation was observed In vitro, PG fractions were able to 
stimulate Τ lymphocytes from these arthritic rats To inves­
tigate the contribution of cross-reactmty, Lewis rats were 
primed with SCW in Freunds incomplete adjuvant (SCW/ 
FIA) This immunization protocol resulted in m l'i irò stim-
ulatory responses to the SCW antigens and cartilage PG 
antigens, but not to joint inflammation per se Next, papain 
was injected intraarticularly to create a situation in which a 
large amount of potential cross-reactive cartilage epitopes 
are released Interestingly, no inflammatory reaction could 
be observed in the papam-injected joints of SCW/FIA-
primed rats 
These data suggest that cross-reactivity between bacterial 
epitopes and PG does not seem to be a key element in the 
onset of joint inflammation in bacterial-induced arthritis 
However, it cannot be ruled out that at later time points 
cross-reactivity will contribute to joint inflammation t ι»ι 
ЛсаЛчаІе Pre«. Ine 
I N T R O D U C T I O N 
Chronic polyarthritis can be induced in susceptible 
rat strains by either structures of the joint itself, like 
collagen type II (1), or by bacteria Two well-studied 
bacterial models are the adjuvant arthritis (AA), in­
duced by an intradermal immunization of heat-killed 
mycobacteria suspended in Freund's incomplete adju­
vant (FIA) (2), and the streptococcal cell wall-induced 
arthritis (SCW-A), which can be induced by a single 
intraperitoneal injection of a sterile, aqueous suspen 
sion of SCW (3) For AA and SCW-A, both polymorph 
and mononuclear phagocytic cells (3, 4) as well as Τ 
lymphocytes (5-7) play an important role in the devel­
opment and maintenance of disease In addition, we 
showed that the susceptibility to SCW-A in the Lewis 
and F344 strains appears to be correlated with the abil­
ity to mount a marked Τ cell response against SCW 
material (8) 
However, the exact pathogenesis of these bacterial-
induced arthritis models is still unknown Several in 
vitro studies suggest that cross-reactivity between bac­
terial epitopes and cartilage may play a role in disease 
development (9-11) In addition to this, it is possible to 
induce arthritis in BALB'c mice by immunization with 
human fetal PG(12) 
Interestingly, in vivo studies which do indicate that 
cross-reactivity may play an active part in disease de­
velopment are very limited In this respect, two studies 
reported modulatory effects with PG fractions (11, 13) 
However, whether these observed effects may also sup­
port that cross-reactivity is the initiating factor lead­
ing to disease development remains to be elucidated 
(14) 
Therefore, we performed this in vwo study to exam­
ine the relevance of in vitro cross-reactive responses 
against cartilage PG in the pathogenesis of bacterial 
arthritis First, we investigated by histological analy­
sis of Safranin-0 stained total knee joint sections, 
whether cartilage of the inflamed ankle joints was de­
pleted of PG at different time points after arthritis in­
duction Compared to the collagen-induced arthritis 
(CIA) only limited damage was found in the bacterial 
models, which is not compatible with a strong autoim­
mune component Moreover, we looked m vitro wheth­
er we were able to detect any stimulatory effects by PG 
fractions in lymphocytes from AA and SCW-A rats 
Finally, we performed experiments in which the cys-
tein protease papain was injected intraarticularly in 
SCW FIA-primed rats (instead of intraperitoneal 
model) Injection of papain resulted in a marked deple 
tion of PG within 24 hx, thus providing high levels of 
potential cross-reactive PG epitopes to initiate inflam­
mation However, signs of persisting inflammation 
were absent 
Our data show that it is unlikely that the observed 
cross-reactive Τ cell responses between bacterial 
epitopes and PG are important mechanisms leading to 
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joint inflammation in SCW-bacterial arthritis How­
ever, whether these cross-reactive responses become 
more important during the chronic phase of the arthri­
tis cannot be ruled out 
MATERIALS AND METHODS 
Rats 
Female Lewis rats were originally obtained from the 
Zentral Institute for Versuchstierzucht (Hannover, 
Germany) and were bred in our own facilities The rats 
weighed between 140 and 170 g at the beginning of 
each experiment and were fed standard food and tap 
water ad libitum 
Induction of Arthritis 
AA was induced by an intradermal injection at the 
base of the tail with 100 μΐof 10 mg/ml mycobactenum 
tuberculosis (M tb ) (H37RA, Difco Laboratories, Ine , 
Detroit, MI) suspended in FIA (Difco Laboratories) Be­
fore injection the M tb was finely ground in a pestle 
and mortar and suspended evenly in FIA 
SCW-A was induced by an intraperitoneal dp) injec­
tion of a sterile, aqueous suspension of SCW m a dose 
of 10 μg murarme acid g rat body wt In order to obtain 
this SCW material, Streptococcus pyogenes T12 organ­
isms were cultured overnight in Todd-Hewitt broth 
Bacteria were kindly provided by Dr H Verheul (Or­
ganon International, Oss, The Netherlands) After me­
chanical disruption (Braun MSK Cell homogemzer), 
the material was treated with RNase, DNase, and 
trypsin as described (3) Cell walls were further iso­
lated by differential centnfugation steps as described 
(15), and the resulting 10,000g pellet was used 
throughout the in vivo experiments, while the 
100,000,? pellet was used in vitro The 10,000g prepa­
ration contained 15% muramic acid (16) 
Type II CIA was induced by an intradermal injection 
into the tail base of 2 mg of native bovine nasal septum 
type II collagen The type II collagen was prepared by 
standard procedures (17) and was prepared for injec­
tion at a concentration of 20 mg/ml in a 50 50 emulsion 
of 0 1 M acetic acid and FIA 
Priming of Rats 
Female Lewis rats were primed in both forepaws by 
a subcutaneous injection of arthntogenic SCW frag­
ments or ovalbumin (Sigma Chemical Co , St Louis, 
MO) emulsified in FIA (100 μΐ per injection site) The 
respective doses of antigen were 1 mg/ml muramic acid 
or 1 mg/ml ovalbumin Ten days later, animals re­
ceived a subcutaneous booster of 100 μΐ at each side 
Τ Cell Proliferation Assay 
In the arthritis experiments popliteal lymph node 
were removed aseptically 10 days after arthritis induc­
tion 
After a single cell suspension was made the leuko­
cytes were washed twice with RPMI (Flow Labs Ine , 
McLean, USA) Adherent cells were removed by incu­
bating the cells in a plastic culture flask (Costar) in 
RPMI containing 10% fetal calf serum (FCS) at a cell 
density of 5 x 106/ml After 1 hr in a CO¿ incubator 
nonadherent cells were aspirated and pooled per group 
Next the cells were put into culture with a final density 
of 1 χ 10e/ml in 0 2-ml vol of RPMI + 109c FCS + 10 
mM pyruvate f 20 mM glutamine ι 5 μΜ ß-mercap-
toethanol + 40 μβ ml gentamycin Cells were cultured 
in 96-well round-bottom plates (Costar) for 3 days with 
variable concentrations of different cartilage compo­
nents, bacterial antigens (100,000/* pellet of SCW or 
M tb ), or control stimuli Subsequently, 37 kBq 
[1H]thymidine was added per well and cells were har­
vested 18 hr later All cultures were done in triplicate 
and pools of popliteal lymph nodes of three different 
animals were always used 
Stimuli for Τ Cell Proliferation m Vitro 
The PG subfractions were prepared as described ear­
lier (18,19) 
Peptidoglycans were prepared from arthntogenic 
SCW material using a formamide extraction Briefly, 
400 mg lyophihzed SCW peptidoglycan-polysac-
chandes was added to 100 ml formamide (J Τ Baker, 
Deventer, The Netherlands) and heated at approxi­
mately 170°C for 1 hr (20, 21) The mixture was then 
centnfuged at 30,000g for 30 min to pellet the pepti-
doglycan fraction This formamide extraction was re­
peated four times After the final extraction the pepti-
doglycan was washed three times with 0 9% NaCl, di-
alysed against distilled water, and finally lyophihzed 
Peptidoglycan fractions always contained less than 2% 
rhamnose by weight as determined by the method of Ζ 
Dische (22) 
The cesium chloride (CsCl) top fraction (protein-rich 
fraction of bovine cartilage PG) was kindly provided by 
Dr R Kuijer (Department of Orthopedics, Maastricht) 
Briefly, proteoglycans were separated in collagen type 
II and PG by guanidinium chloride extraction (23) The 
non-CII was further separated by density centnfuga­
tion (1 47 g,ml CsCl, 108,000^, 10°C, 50 hr) in a pro-
tein-nch (top) and a PG-nch (bottom) fraction 
Con A (Flow Labs Ine ) was used as a positive con­
trol 
In Vivo Cartilage PG Depletion 
Cartilage PG depletion of knee and ankle joint in 
SCW-primed rats was induced by intraarticular da) 
injection of 1% papain (Merck, Darmstadt, Germany) 
in 10 μΐ phosphate-buffered saline (PBS) into the right 
knee and ankle joint of each animal As a control, an 
equal volume of PBS was injected into the left knee and 
ankle joint 
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Measurement of Unilateral Joint Inflammation 
The level of joint inflammation was measured by the 
" T c uptake method (24) Briefly, rats were anesthe-
sized with pentobarbital (300 mg/kg) and 0 2 ml (7 4 
MBq/ml) " m Tc was administered subcutaneously Af-
ter 30 min the MmTc uptake in the right and the left 
knee and ankle joint was measured by external gamma 
counting The uptake of this small radioisotope is a 
measure for local blood flow and edema The seventy of 
inflammation is expressed as right over left ratios and 
all values exceeding 11 were assigned as inflamma-
tion Joint inflammation was also scored histologically, 
as described below 
Histology 
Knee and ankle joints were removed in toto and pro-
cessed for histology as described (25) Seven-micro-
molar sections were stained with either hematoxylin 
and eosin (H&E) to determine the level of inflamma-
tion or with Safranin-0 which stains glycosaminogly-
cans, diminished staining would therefore represent 
PG depletion Scoring of inflammation and PG deple-
tion was done by two independent observers 
RESULTS 
Cartilage Destruction in Bacterial Arthritis Models 
In order to examine the occurrence of cartilage PG 
depletion in bacterial arthritis, Safranin-0 stained sec-
tions of ankle joints were analyzed at various phases of 
AA and SCW-A At least four animals per time point 
were sacrificed and both ankle joints were examined 
for PG depletion 
AA developed in all Lewis rats with an onset around 
Day 13 Sections taken at Day 17 revealed massive 
inflammation in the synovial tissue, but hardly any 
detectable loss of proteoglycans in the cartilage layers 
In fact, the cartilage of the talus and tibia appeared 
normal and minimal signs of depletion were noted at 
the margins underneath developing pannus tissue 
(Fig la) At later time points (Days 28 and 34) exten-
sive bone marrow inflammation and bone erosion was 
found, but the cartilage of the talus and tibia remained 
unaffected (Fig lb) Distinct cartilage PG depletion 
was regularly noted in a restricted, central area be-
tween the tarsal bones, showing outgrowth of granu-
lation-like tissue (Fig lc) 
In the SCW-A model all Lewis rats developed a 
chronic arthritis, with a gradual onset in the ankle 
joints around Day 5 Sections taken at Days 7 and 10 
showed a remarkable absence of cartilage PG loss, 
comparable to the observations in AA (Fig Id) At 
later time points (Day 17) the degree of inflammation 
varied considerably, but even in severe cases cartilage 
PG depletion was restricted to the central area of the 
tarsal bones and the margins underlying pannus over-
growth 
For comparison, similar sections were taken from 
ankle joints of Lewis rats with collagen arthritis In 
our hands, 75% of the animals developed an arthritis 
around Day 16 and these positive rats were further 
examined at Days 23 and 30 Cartilage PG depletion 
was clearly present in large parts of the cartilage, in-
cluding the talus and tibia, and destruction was more 
marked at Day 30 Consistent with an autoimmune 
attack at the collagen type II-containing cartilage, 
even complete loss of the undecalcifíed cartilage layer 
was often found (Fig le) 
Τ Cell Response to Cartilage PG 
To test whether any cross-reactive responses against 
cartilage were present in AA and SCW-A, a lympho­
cyte proliferation assay was performed on the popliteal 
lymph nodes 10 days after arthritis induction A sum­
mary of the m vitro stimulatory effects for the various 
antigens is shown in Table 1 Τ cells from AA rats 
displayed a clear response to the bacterial antigen 
M tb and a significant response to the PG fractions 
Regarding the Τ cells from SCW-A rats, only a low 
but significant response was observed against the in­
jected antigen Interestingly, the Τ cells responded bet­
ter to the peptidoglycan than to the SCW material, 
suggesting that the main Τ cell epitopes of SCW are on 
the protein-rich fraction and not on the polysaccharide 
part of SCW Furthermore, we were able to detect sig­
nificant responses against the chondrosarcoma extract 
and link protein and an additional reactivity to the PG 
binding region 
Joint Inflammation Due to Cross-reactive Immunity 
To prime for cross-reactive responses Lewis rats 
were immunized with emulsified SCW/FIA, a protocol 
which does not lead to arthritis development The level 
of immunity in either the SCW/FIA or the control 
group (OVA/FIA) was tested in a lymphocyte prolifer­
ation assay Both groups of animals showed high re­
sponses against the antigen to which they were immu­
nized and only low responses to the control antigen In 
addition, the SCW-pnmed Τ cells did show a signifi­
cant response against the protein-rich fraction of-bo­
vine cartilage PG (Table 2) 
To examine the potential contribution of this cross-
reactivity to arthritis, papain was injected at Day 27 in 
right knee and ankle joints to release cartilage PG 
epitopes Three days later, the level of inflammation 
was determined by the 9 9 mTc uptake method No swell­
ing or edema could be detected in either group The 
histology (H&E-stained sections) did confirm the M m T c 
uptake data, since almost no inflammatory cells could 
be observed in both ankle and knee joints (Table 3) In 
addition, sections were stained with Safranin-O to ver-
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FIG. 1. Light microscopic analysis of cartilage PG depletion in Safranin О stained ankle joints in different arthritis models la) Adjuvant 
arthritis, Day 17. (b, c) Adjuvant arthritis, Day 28 (d) SCW-A, Day 17. (e) Type II collagen-induced arthritis. Day 23. (f) Negative control. 
JS, joint space; TL, talus; TS, tarsus; ТВ, tibia; C, cartilage. 
ify whether the cartilage was depleted of PG due to the 
papain injections. In all Safranin-O stained sections of 
the right joints marked depletion of PG was observed. 
DISCUSSION 
Several in vitro studies do indicate that cross-
reactivity between bacterial epitopes and cartilage 
may play a role (9-11); however, in ілио studies which 
support this hypothesis are very limited (11, 13). 
Therefore, we performed this in vivo study in both AA 
and SCW-A. 
Histological analysis using Safranin-0 stained sec­
tions showed only minimal PG depletion in both AA 
and SCW-A. The observation that some depletion was 
present in the areas of invading pannus are in agree­
ment with an earlier report in AA (26). However, the 
finding that the cartilage of the talus and tibia was not 
depleted of PG at all has not been reported so far. To 
our knowledge only one other study investigated the 
cartilage of the talus in AA-treated rats by electron 
microscopy. In that study, it was shown that the pro-
teinaceous outer-surface layer of the cartilage was dis­
rupted (27), but whether the cartilage was depleted of 
PG was not investigated. Regarding the SCW-A, it also 
has been reported that extensive cartilage destruction 
does occur (28). However, major destruction was ob­
served at later stages (Day 42), while only minimal 
destruction was observed at earlier time points. 
As suspected, CIA showed prominent PG depletion 
and this was observed early on and throughout the 
entire ankle joint. These data do support earlier stud­
ies with H&E sections, which found that large parts of 
the cartilage became markedly eroded during the ar­
thritis (1, 29). A likely explanation for this extensive 
PG depletion may be that in CIA, not only Τ cells play 
an important role (30), but also anti-СП MoAbs. These 
immunoglobulins attach to the cartilage surface and 
direct the inflammatory process toward this tissue. Of 
interest, CIA can be transferred with these MoAbs 
(31). Extensive cartilage destruction is also reported in 
the PG arthritis (32). 
To conclude, our results of limited PG degradation 
during AA and SCW-A development do not fully sup­
port the hypothesis that arthritis may be initiated by 
structural mimicry between bacterial epitopes and car­
tilage. 
The results of the in vitro study demonstrate that 
during induction of AA or SCW there is a recognition of 
PG components. The proliferative responses of the ar­
thritic lymphocytes to the binding region were better 
in comparison to the whole chondrosarcoma extract. 
Regarding the Τ cells from SCW/FIA-primed mice and 
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FIG. 1—Continued 
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TABLE 1 
Proliferative Response of Lymph Node Cells 10 Days after 
Induction of AA or SCW-A 
Stimulus 
Mtb. 
sew Peptidoglycan 
Link protein 
Binding region 
Chondrosarcoma 
Ovalbumine 
Con A 
Control cpm 
Concentration 
30 u.g'ml 
30 μg'ml 
100 μg/ml 
1:10 
110 
1:50 
30 μβ'πιΐ 
0 6 >tg/ml 
Stimulation index 
AA 
8 
— 2.3 
1.3 
1.9 
1.3 
< 1 
44 
7436 
SCW-A 
_ 
2.3 
4 
2 2 
3.5 
2.5 
< 1 
53 
6076 
Note Proliferation was measured by [3H)thymidine incorporation 
during the last 18 hr of a 96-hr culture with various bacterial and P u 
stimuli Proliferative responses are expressed as stimulation indices 
(amount of radioactivity incorporated due to stimulus X divided by 
that due to medium alone) The values represent the mean of trip­
licate cultures and the variation was always <Л0% Lymph nodes 
from three animals per group were pooled. Experiment shown rep­
resents one out of two experiments 
Τ cells from AA rats, this has already been reported 
(10, 11), but in the SCW-A model in the Lewis rat this 
is the first report which shows cross-reactive responses 
against PG fractions. Some of the responses in AA were 
only minimal, but it cannot be ruled out that other 
components, such as keratan sulphate, chondroitin sul­
phate, or core protein, may induce higher responses 
(11). Furthermore, our data also indicate that intact 
native PG is antigenic, but PG subfractions are even 
more antigenic, which may suggest that degradation of 
PG during disease progression can expose sequestered 
or cryptic epitopes which are even more antigenic. The 
higher responses against peptidoglycans in the SCW-A 
may be explained by the fact that the degradation-
resistant polysaccharide groups mask the antigenic de-
TABLE 2 
Proliferative Response of Lymph Node Cells 23 Days after 
Immunization and Booster with SCWFIA or OVA'FIA 
Stimulus 
SCW 
OVA 
CsCL top 
Con A 
Control cpm 
(ig/ml 
6 
30 
30 
0 6 
Stimulation index 
SCW'FIA 
29 
2 
6 
168 
901 
OVA/FIA 
3 
8 
2 
62 
1848 
Note. Values represent the mean incorporation of [3H]thymidine 
given as a stimulation index (amount of radioactivity incorporated 
due to stimulus X divided by that due to medium alone). Lymph 
nodes from two animals per group were pooled and the values rep­
resent the mean of triplicate cultures. Results shown represent one 
out of three experiments Various stimuli are used; SCW, strepto­
coccal cell walls, OVA, ovalbumin, CsCl top, protein-rich fraction of 
bovine cartilage proteoglycan, Con A, concanavalin A. 
TABLE 3 
Effect of ia Injection of 1% Papain in Both Right Knee and 
Ankle Joint 30 Days after Immunization with SCW/FIA 
or OVA/FIA 
R'L ratio of " T c uptake Histological score*) 
Immunization Knee joint Ankle joint Right knee Right ankle 
SCWfFIA 1 1 ± 0 08 1 06 ± 0 09 0 4 : 0 3 0 2 ± 0.1 
OVAFIA 108 ±0.1 107 ± 0 07 03 ± 0 2 02 ± 0 1 
Note R L ratios of э Т с uptake 3 days after intraarticular injection of 1% 
papain in SCW FIA or OVA'FIA immunized animals Values represent the 
mean ± SD from groups of eight animals After the """Tc uptake assay the 
joints were removed and the sections stained with hematoxylin and eosin 
Inflammation was scored on coded slides, using a scale from 0 to 3 by two 
independent observers 0, no inflammation, Э, large mass of inflammation 
terminants on the peptidoglycans. It also suggests that 
peptidoglycans contain most, if not all, Τ cell epitopes 
for SCW-primed Τ cells. That peptidoglycans are not 
capable of inducing chronic arthritis is due to lack of 
persistence. In this respect, the polysaccharide is of 
importance, since it protects the peptidoglycan from 
being rapidly degraded (14). 
To investigate the relevance of the in vitro cross-
reactive responses in pathology, Lewis rats were im­
munized with SCW/FIA. Depletion of PG by an in­
traarticular injection of papain did not lead to joint 
inflammation. These data suggest that SCW-specific Τ 
cell responses, which in vitro cross-react with the pro­
tein-rich subfraction of PG, are not able to initiate an 
inflammation in our experimental circumstances. To­
gether with the histological findings in AA and SCW-
A, this indicates that it is unlikely that cross-reactivity 
to PG fragments is the initiating factor leading to joint 
inflammation in these models. 
Several data do support the latter conclusion. First of 
all, it has been found in the SCW-A that a clear corre­
lation exists between SCW dissemination and persis­
tance in the joint and chronicity. Treatment with mu-
tanolysin resulted in a decline of the chronic phase of 
arthritis (33). Mutanolysin degrades cell walls to small 
fragments, which show poor persistance in the joint 
and limited artritogenicity. In this respect SCW-A dif­
fers from AA. Furthermore, attempts to induce arthri­
tis with subfractions of PG alone showed that these 
were never arthritogenic by itself (11). The finding that 
arthritis can be induced with human fetal PG (12) sug­
gests that fetal PG are different in comparison to ma­
ture PG and that other epitopes are involved in PG and 
bacterial arthritis. 
All together, we suggest that cross-reactive re­
sponses to PG fragments, which are present during the 
onset of disease, are not playing a pivotal role in the 
induction of arthritis. However, since arthritis can be 
modulated with PG fragments (11,13), it appears that 
these cross-reactive responses are under control of sim­
ilar regulatory mechanisms (34). An identical conclu­
sion can be hypothesized from the 65-kDa experiments. 
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These data show that both AA and SCW-A can be mod­
ulated with 65 kDa (35, 36), and that responses against 
65 kDa can be detected in animals with a bacterial-
induced arthritis, but 65 kDa by itself is not arthnto-
gemc (37) These results also indicate that responses 
against 65 kDa are not involved in the actual patho­
genesis of bacterial arthritis, but probably act on reg­
ulatory mechanisms 
It is important to realize that our study, aimed at the 
release of cross-reactive PG epitopes, was performed 
with papain and it cannot be excluded that endogenous 
enzymes like cathepsins or metalloproteinases may re­
lease other, more relevant epitopes Studies are now in 
progress to address this issue 
In conclusion, our results imply that during the on­
set of disease, the observed m vitro cross-reactivity be­
tween bacterial epitopes and PG may not be the initi­
ating factor leading to joint inflammation However, 
whether these cross-reactive responses may contribute 
to disease progression instead of disease induction re­
mains a matter of debate 
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in the Lewis rat 
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SUMMARY 
Adjuvant arthritis (AA) can be induced m Lewis rats by a single injection of either heat-killed 
Mycobacterium tuberculous or the lipoidal amine CP2096I Concanavahn A (Con A)-stimulatcd Τ 
cells isolated from A A rats are able to adoptively transfer the disease to naive syngeneic recipients It 
is unclear, however, whether these transferred cells traffic directly to the joint and initiate arthritis, or 
whether secondary host cells arc responsible for activation of the disease In the current investigation, 
Τ cells labelled with the vital fluorescent dyes Hoechst H33342 and Zynaxis PK.H26-G were used to 
adoptively transfer adjuvant disease to naive recipients At various stages of disease development 
sections of ankle joints, together with a range of soft tissues, were examined by fluorescence 
microscopy to determine the distribution of labelled donor cells in the recipients Intensely 
fluorescent lymphocytes were observed in the liver, spleen and lymph nodes within 24 hr of adoptive 
transfer Foci ofsuch cells were clearly visible in the primary lymphoid tissues as late as 14 days after 
transfer However, close examination of both ankle joint sections and patellar fat pad cells 
throughout the time-course of the study failed to delect any labelled cells at the lesion site To develop 
these observations further we performed adoptive transfers to nude Lewis rats (rnu/rnu) and found 
that they were only moderately sensitive and developed, at best, a transient arthritis This observed 
difference could not be explained by a generalized lack of an inflammatory response, since we were 
able to elicit a zymosan peritonitis in the nude rats However, in nude Lewis rats a striking increase in 
adoptively transferred A A was obtained after reconstitution with 4 χ 10s naive syngeneic spleen cells 
These combined observations suggest that a host-derived immune cell population is crucial for 
arthritis induction in the adoptive transfer system 
INTRODUCTION 
Rat adjuvant arthritis (AA) is a well-defined model of human 
rheumatoid arthritis that can be induced by immunization of 
Lewis rats either with Mycobacterium tuberculosis (Mtb) sus­
pended in Freund's incomplete adjuvant (FIA),1 or with the 
lipoidal amine CP20961 m paraffin oil2 Fourteen days after 
induction, a progressive infiltrate of mononuclear cells is seen in 
(he anklejoinls, with concomitant early signs of bone remodell­
ing Several studies have already shown the important role of Τ 
lymphocytes in this arthritis model AA cannot be induced in 
athymic (nude) rats,* treatment of rats with anti-T-lymphocyte 
antibodies prevents the induction of disease,41 and, finally, the 
disease can be transferred to naive or irradiated syngeneic 
recipients with concanavahn A (Con A)-expanded T-cell lines6 
or clones 7 
The possibility that Τ lymphocytes can migrate specifically 
to the inflammatory site has been examined in several models 
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recently In a dermal inflammation model, it has been demon­
strated that a unique, small population of peritoneal exudate 
lymphocytes can migrate preferentially to cutaneous inflamma­
tory sites8"11 and reside there for long periods of time This 
contrasts with the kinetics of lymphocyte migration into the 
arthritic joint, which appears to be a major traffic site for all 
lymphocytes, although they appear to reside there for only a 
relatively short time , : Furthermore, reports on the autoimmune 
disease experimental allergic encephalomyelitis (EAE), show 
that only a small percentage of transferred myelin basic protein 
(MBP)-reactive Τ cells accumulates in the central nervous 
system11 ы and that non MBP-reactive lymphocytes ('bystander 
cells1) can also play a role in mediating passively transferred 
EAE' 1 
Recently, De Jo y et α/16 reported that in the adoptive 
transfer of AA some of the donor Τ cells (adjuvant sensitized) 
migrate to the synovium, where they may be responsible for 
disease induction However, subarthntogenic doses of affinity-
punned anti-collagen IgG wereco-mjected to facilitate adoptive 
transfer of AA, thereby inducing a more rapid onset of disease 
Since this lesion appears to be complement dependent,1T the co-
ïnjected anti-collagen IgG may stimulate the influx of inflamma-
tory cells, including the transferred AA celts Thus it still 
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геішіпч lo bc demonstrated in the Ll.issii.al adoptive iransler 
svsiem ' which is primarily mediated by cellular immune 
mechanisms whether donor Τ lymphocytes ate capable of 
specilla migration to joints and subsequent initiation ol arthritis 
We therelore t a m e d oui adoptive iransler experiments ol 
AA to naive recipients using either N11142-'' or P K H 2 6 - | g 
labelled Con A-stimulaled Τ cells At various stages of disease 
development ankle joints and a range ol solt tissues were 
examined bv fluorescence mieroseopv lo investigate whether 
anv donor Τ lymphocytes could be delected Additionally 
adoptive translcrexpcrimentswcre pei formed on immunocom­
promised recipients to determine whether a host-derived cell 
population plays an important role in the induction ol disease in 
the adoptive iransler system 
We were not able to detect anv labelled cells m ihe joints 
suggesting that the cellular infiltrale, at the lesion site is host 
derived Transfer experiments to nude Lewis reeipicnls sup­
ported this hypothesis, since only moderate arthritis developed 
in these animals 
M A T F R I A I S A N D M F T M O D S 
Ruts 
bemale lewis rais were onginallv obtained I rom the Zentral 
Institute fur Versuchsticr/uchi (Hannover Germany) and bred 
in our own Utilities or weie Irom Olac Bicester I К Iemale 
lewis rnu rnu were obtained from Mollegaard (Skcnsved. 
Denmark) The rats weighed between 140 and 170 g at (he 
beginning of each experiment and were fed standard lood and 
tap water atl libitum 
itfopiiu transit' of афш ant arthritis 
The technique used was that described bv Taurogr/w/ ' Bneflv 
Iemale inbred I cwis rais were injected umadcniiallv at the base 
of the tail and the hind paws with 2SO /ig ol Mtb (heat-killed 
human strains С . D T and PN Central Vetermarv Laboratorv 
Wevbridge Ι ' К > The Mtb was linclv ground in a pestle and 
mortar and suspended evenlv in light paralhn oil al a concentra­
tion ol 2 S mg ml In case of the PKH26-GL labelling experi­
ments donor cells originated Irom С P2(W61 (Phzei C r o t o n 
С Τ) (S mg ral in 0 I ml paralhn oil) primed animals 1 en davs 
.liter injection popliteal inguinal and subaortic Ivmph nodes 
and spleens weie removed ascplieally Alter a smidc-ccll 
suspension was made the f lymphocytes were purified bv 
passage over a nylon-wool column Τ cells were then stimulated 
with С on A ( H o w Labs McLean VA) (1 /ig ml) lor 48 hr m 
RPMI supplemented with 10'. fetal call serum (PCS) 10 m\l 
pvruvaie 20 mvi glutamine and 40 /ig ml gcnlamycin (How 
I abs) at a concentration ol 2 S ν I О*1 cells ml Alter incubation 
Τ Ivmphoevles were washed in phosphaic-buirercd saline (PBS) 
and either labelled or immediately miected intravenouslv into 
naive svngeneic recipients or irradiated iccipicnts as stated 
(S χ ΜΓ cells recipient) Arthritis developed within S davs and 
was scored macroscopicallv bv measuring hind paw thickness 
with an industrial micrometer or using the scoring svstem ol 
Billmgham ft at ' 
/ аЫ Итц of tiansft rreil 11 tt\ 
\l Ihe end ol ihe in ι uro С on A stimulation AA Τ cells were 
harvested and washed three times with PBS at room tempera­
ture These viable cells were then stained with either H11142 
(Calbiochem La Jolla С Л) or P K H 2 6 - 0 1 (/vnaxis Malvern 
P*\) dye The M1H42 labelling was performed according to 
methods ol I oefflcr ft at '* Bneflv lymphocytes were resus 
pended in a scrum Ircc Hanks balanced salt solution (HBSS) 
containing 1 /i\! H11142 at a concentration of IO6cells ml and 
incubated lor 10 min in α 17 water bath with gentle agitation 
Cells were then washed twice in NBSS and viahilnv and 
fluorescence were assessed bv microscopic observation 
Labelled Τ cells were then used to transfer arthritis to naive 
animals 
The PKH26-GL labelling was pcrlormcd according to 
methods ol l loran et af !У Briefly 1 ч Hf cells suspended in S ml 
o f t h e k i i ( Z v n a x i s ) d i l u e n i w a s a d d c d i o a l u r t h e r S m l o l diluent 
containing 4/I\I PKH26 (»Land incubated lor 2 1 mm at room 
temperature with gentle shaking The reaction was stopped bv 
the addition of an equal volume of I C S lor S mm 1 wentv live 
millilitres ol RPMI supplemented with 10 ( C S was subse 
quenllv added and the cells weie pelleted bv centrifugaron at 
4(H) я lor 10 mm Cells were then washed twice once with RPMI 
supplemented with 10 ' I C S anil once with PBS The fluores­
cence and viability were assessed by mieroseopv before intra 
venous (ι ν ) inaction into naive recipients 
In vitro nntofun stimulation 
In order to assess the effects ol cell division on fluorescence 
intensity labelled donor Τ Ivmphoi vies were maintained in 11 tro 
in the presence of С on A (1 /ig ml) for 7 days The cultures were 
examined daily and the percentage labelling established b\ 
determining the ratio ol fluorescent to non-lluoresceni cells 
This was accomplished by counting (he same haemoevtomcter 
held under both fluorescent and normal illumination 
In vivo nit aaffn ι \pcimunis 
\dopiivc transfer experiments with rl1H42-labelled cells were 
performed lour times and these data comprise the following 
davs posl-transfcr 1 2 1 4 S 7 9 10 H a n d 14 Adoptive 
iransler experiments with PKH26-GL-labeiled cells were per 
lormed twice and comprise davs 2 S 7 9 and 11 posl-lransfcr 
At all the above lime points groups ol three recipients were 
killed and inguinal and popliteal lymph nodes thymus spleen 
liver and ankle joints were removed and immediately submerged 
in liquid nitrogen Multiple cryostat sections were cut and 
examined bv fluorescence microscopy for the presence of 
labelled cells 
In the Ivmph nodes at least three serial sections at different 
levels in the block were examined I or the larger organs e g 
liver and spleen at least three sections were taken again at 
multiple levels in order to obtain as representative a sample as 
possible Three sections from at least two levels were examined 
in the joints Peripheral blood samples were collected Irom the 
dorsal aorta and leucocytes isolated bv sedimentation m 0 s 
niellivi cellulose The percentage ol labelled cells in the bulTy 
coat was then determined as described above 
Pau fiai fat pad alls 
At davs 2 S 7 and 9 two recipients were killed and the patellar 
fat pads removed Single-cell suspensions were made bv en/y 
malic digestion using the method described bv Dc|oy it at 
Briefly the patellar fat pads were digested in serum-lrce RPMI 
supplemented with 0 S mg ml eollagenasc 0 15 mg ml DNase 
and 0 OS mg nil hvaluromdase (Sigma Chemical С о , St Louis 
MO) After 00 mm ot gentle agitation .it 17 the cell suspension 
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Figure 1 Comparison of the seventy of AA after iidopiivL transfer *ith 
cither labelled (N11142 or PKH26 CiL) or non Id bel ltd Τ lymphoevtes 
Arthritis was scored as the sum ol paw thickness of both hmdlegs(cm) 
E-aJi group consisted of four animals 
was centnfuged ai 400 g and the cells washed with RPM1 This 
suspension was filtered through a 6O-/1M Nytex liller (Tciko 
Elmsford, NY), and at least 100 cells examined by fluorescence 
microscopy 
Irradiation of the reapwnti 
Groups of four recipient L cwis rats were exposed to 2 S or S Gy 
total body irradiation (TBI) The physical parameters of the X-
îrradiation were 18 MV, field size, 40x40 cm1, dose rale 
"* Gy min One hour after irradiation, arthritis was induced 
by adoptive transfer of Mlb-pnmcd non-fluorochrome-
I a bel led Τ cells 
huhu tum of sterile pi ritorni ¡s 
I our rats from the control non-rcconstituled nude and S (un-
irradiated groups were injected intrapcnioneally (ι ρ ) with 18 
ml of saline containing 1 Ό glycogen (Merck Darmstadt 
Germany) or 5 mg of ¿ytnosan (Sigma ( hemtcal Co ) Irradia-
tion was perlormcd cither 2 or S days before induction of the 
peritonitis Sixteen hours after injection rats were killed and the 
peritoneal cavity washed once with 40 ml of saline The elicited 
peritoneal cells were washed, the total cell number determined 
using a Coulter counter, and differential leucocyte counts 
performed on Wright Giemsa-staincd cylospin preparations 
At least 200 nucleated cells were identified as polymorpho-
nuclear cells (PMN) or monocytes (Mo) 
In vttro mitogen stimulation 
H11142-labcllcd lymphocytes were cultured m ι tiro with Con A 
to investigate whether, during proliferation the dye was lost due 
to dilution Initially, all cells look up (he label and, following 7 
days ol »1 litro stimulation with Con A, 92"< of viable cells 
remained fluorescent PKH26-GL has already been shown to be 
detectable in tuo after 121 days ""** Previous transfer experi­
ments had shown that recipient animals developed macroscopic 
and histological signs of arthritis as early as 4 days following 
injection ol donor cells These data therefore suggest that bolh 
dyes can be used effectively lo determine the distribution of 
transferred cells during the period ol lesion development 
In ι ivo cell traffic experiments 
Since the labelled cells were still clearly fluorescent lollowing 
proliferation adoptive transfer experiments were performed 
with bolh dyes to ascertain whether either label affected the 
severity ol the arthritis Labelled AA cells were transferred to 
naive recipients where it was lound that neither label had any 
apparent а Пес l on the incidence or seventy ol the arthritis in 
comparison with non-labelled cells (Tig I) Time course experi­
ments were performed subsequently using either the H11142 or 
the PK.H26-GL dye winch label the cell nucleus and cvioplas-
mic membrane respectively The results of the cell trafficking 
experiments were identical lor bolh dyes and repicsenlalivc 
pictures ol both dye arc shown in big 2 
Al day 1 post-iransfer the majority ol fluorescent cells were 
localized in the liver and spleen Small loci ol positive Ivmpho-
cylcs were observed in the popliteal and inguinal lymph nodes 
Approximately 5 . of the peripheral white cells were stained al 
this time this increased lo a maximum of 90' 1 on day 2 before 
falling to non-delectable levels at all subsequent time-points At 
days 2 and 1, Ihe number of clearly labelled cells in the livci and 
spleen was seen 10 decrease whilst their frequency in the Kmph 
nodes increased From days 4 to 14 loci ol clearly labelled 
lymphocytes were still observed in Ihe ly mph nodes and spleen, 
bul al ihe later lime-points ihcir numbers were reduced During 
the same period the liver and spleen developed a progressive 
a ut о flu orescent appearance which was particularly marked in 
the animals which received Η11142 labelled cells Macrophages 
sequestered the dyes and exhibited inlcnsc particulate cytoplas­
mic fluorescence Throughout the entire lime course of the 
experiment no labelled cells were observed in the thymus 
The examination of ankle joints al all time-points failed to 
reveal the presence ol labelled cells at the lesion site, despite 
multiple sectioning at different levels of the block The absence 
of labelled cells in the joint was not due a lack of lesion 
development since in each adoptive transfer experiment macro­
scopic symptoms of arthritis were clearly observed 
Patellar Tat pad studies 
Single-cell suspensions of patellar fat pads, prepared by enzy­
matic digestion, were examined b\ fluorescence microscopy No 
labelled cells could be detected al any time-point 
Adoptive transfer to immunocompromised recipients 
To determine whether a host-derived T-cell population is 
essential for arthritis induction, adoptive iranslcr experiments 
lo immunocompromised (T-cell depleted) recipients were per­
formed Rats that had received 2 5 Gy TBI developed a slightly 
less severe arthritis compared with controls However reci­
pients that had received 5 Gy TBI developed a significantly 
milder arthritis (P<0 02. Wilcoxon rank test) (Pig 3) 
Adoptive transfer experiments were also performed with 
nude [ ewis (rnu rnu) rats which are profoundly deficient in 
mature Τ lymphocytes ' ' These experiments resulted in the 
initial development of a mild arthritis which failed to progress 
{P<~0 01 Wilcoxon rank test) compared with the control Lewis 
rais (Fig 4) 
Subsequently, AA was transferred to nude recipients which 
had been reconstituted with 4 χ 10й naive syngeneic spleen cells 
I day before the adoptive transfer Although no significant 
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lij>ure 3. Adoptive transfer of А Л lo irradiated and non irradiated 
recipients. Arthr i t is was scored as the sum of paw thickness of both 
liimJlctis lem) Each group consisted of four animals Data were tested 
with the Wilcoxon rank test ( * / > < 0 0 2 ) 
di f ference was observed at the onset o f disease (nudes versus 
r e c o n s t i t u t e d nudes), it appeared t h a t at later l i m e - p o i n t s the 
a r t h r i t i s was s i g n i f i c a n t l y m o r e severe a n d c h r o m e ( # * < 0 Ό 5 : 
W i l c o x o n r a n k lest) in the r e c o n s t i t u t e d n u d e recip ients ( F i g . 4) . 
It was n o t e d that a b o u t 7 5 % o f the n u d e recipients, b u t not 
the r e c o n s t i t u t e d n u d e rats, d i e d between day 22 a n d d a y 30 
post-transfer. M a c r o s c o p i c analysis d i d n o t show any signs o f 
graf t-vcrsus-host disease. 
I n d u c t i o n o f ster i le per i ton i t is 
A d o p t i v e t r a n s f e r t o T-cel l depleted recipients resulted in a m i l d . 
non-progress ive a r t h r i t i s . A steri le p e r i t o n i t i s was therefore 
i n d u c e d in c o n t r o l , i r r a d i a t e d a n d n u d e L e w i s rats t o d e t e r m i n e 
w h e t h e r such a n i m a l s d i s p l a y e d a general ized i n a b i l i t y t o m o u n t 
an i m m u n e response I n i r r a d i a t e d I ewis rats, it was f o u n d that 
the i n f l u x o\ i n f l a m m a t o r y cells was m a r k e d l y reduced c o m ­
pared t o that o f c o n t r o l rats. I n c o n t r a s t , the n u d e I ewis rats 
ю 
15 20 
Time (days| 
І-іцш-г 4. Adoptive transfer of A A to naive lewis 
( R N U ) rats and nude Lewis recipients reconstituted 
spleen cells ISC") ! day before transfer Arthrit is was 
calliper and the values represent the s 
hmdpaws (cm) I ach point represents 7 14 animals Data were tested 
with the Wilcoxon rank test. Differences between the nudes and ihe 
naive lewis rats were significant, *P< 0 01 I urthcrmorc. the differ­
ences between the nudes and the reconstituted nudes were significant, 
**/». (IOS 
[s. nude Lewis 
h 4 - lu" naive 
•asured using a 
thickness of both 
I a hit- 1. Peritoneal recruitment assav nmunocompromiscd animals 
Recipient 
Γ\ρ 1 
Lewis 
Lewis S ( i \ (day 
Lewis 5 ( r\ (da) 
Exp : 
Lewis 
Lewis R N U 
21 
5) 
" 
1 
4 
4 
4 
4 
Total cell nu 
y II) obtained 1 
peritoneum 
4 1 • J < 
OH * 0-2 
(16.1.1)4 
K4 • 1 (1 
11 4 ± t ) 7 
um 
1 dentil 
111 l 
| > М \ 
Tl - 1 
Ш • 4 
cation 
dis 
M o 
2K + 2 
40 + 4 
Peritonitis was induced in Exp I by injection of I glycogen and m 
Exp _ h> s mg oi zymosan 
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showed the greatest response, recruiting more inflammatory 
cells to the peritoneum than any other group (Table 1) 
DISCUSSION 
Previous studies in rat AA have demonstrated the central role of 
Τ lymphocytes in this model ' 7 Furthermore, U has been 
reported" that a small number οΓΤ lymphocytes can be detected 
by immunocytochcmiL.il analysis of the knee synovium from 
rats undergoing adoptive transfer Whether the transferred Τ 
lymphocytes can migrate specificali) to the joint remains a 
matter of debate Recently, DcJoy et at '* have used an adoptive 
transfer system in which they were able lo recover labelled cells 
from the knee synovium of recipients However, their system 
appeared to be complement dependent as anti collagen IgG was 
co-injected It thus remains to be demonstrated whether donor 
cells can be detected in the joint lesion when (he disease is 
transferred by AA-specific lymphocytes in the absence of co-
injected IgG In the current study, cell traffic experiments were 
undertaken to address this issue 
Confirming earlier studies,1":: : 1 our data indicate that both 
dyes can be effectively used for in ι ivo cell trafficking experi­
ments without affecting the incidence or seventy of arthritis 
This suggests that the labelling docs not alter the functional 
characteristics of these cells Perhaps surprisingly we were 
unable to detect any labelled cells in the ankle joints or patellar 
lat pads at any time-point in our adoptively transferred arthritis, 
this suggests that the cellular infiltrate within the joint lesion site 
is predominantly host derived It has been reported,16 that Τ 
cells are present within inflamed synovium of adoptively 
transferred AA, and we have seen Τ cells in the later stages of 
adoptively transferred disease (unpublished observations) when 
lesions arc well developed However, the appearance of Τ cells 
within lesion sites in the direct form of CP20961 in these Lewis 
rats, occurs much later than inflammatory macrophages, which 
enter the synovium and initiate the arthritis several days before 
Τ cells arrive (S С R MeacockandD R Brandon, manuscript 
submitted for publication) Our present data, therefore, suggest 
that the transferred Τ cells confer arthntogenicity to host cells 
This does not totally rule out the possibility that a few 
transferred Τ cells, undetected during our studies, entered 
putative lesion sites and set the stage for arthritis, they were 
certainly present in lymph nodes at day 14. but the overall lack 
of appearance of labelled cells at lesion sites inters initiation of 
the actual arthritis by host cells 
The above findings are in agreement with the unpublished 
experiments of J D Taurog and colleagues (personal communi­
cation), who were also unable to detect any '"In-labelled 
adoptively transferred cells in the arthritic joint This contrasts 
with adoptive transfer of EAE, where several investigators have 
detected small amounts of labelled cells at the lesion site , J N The 
difference between adoptively transferred EAE and our findings 
in AA may reflect the nature of the priming antigen In EAE the 
donor cells arc pruned against MBP, an antigen that is present in 
large amounts at the lesion site However, it remains unknown 
which antigens are recognized by Mtb- or CP20961 -primed Τ 
cells in joint lesions in cither direct or adoptively transferred 
arthritis 
To support our findings further, adoptive transfer experi­
ments were performed on T-cell depleted recipients Our data 
show that irradiation of recipients reduced their susceptibility to 
development of adoptively transferred AA in a dose-dependent 
manner This finding can be explained by a general immune 
dysfunction in these animals, as exemplified by their inability to 
recruit inflammatory cells to a non-specific peritoneal stimulus 
These observations concur with those of Taurog et ai ,20 who 
have demonstrated that bone marrow reconstitution is essential 
in T-cell depleted recipients for initiation of arthritis 
Adoptive transfer experiments were also conducted in nude 
(rnu/rnu) Lewis rats, which are reported to lack almost all 
mature Τ lymphocytes : 4 The adjuvant disease transferred to 
these recipients was mild and non-progressive The lack of 
disease development could not be explained by a generalized 
immunodeficiency, since they were able to recruit inflammatory 
cells in response to an induced peritonitis Indeed, these nude 
rats were able to recruit even more macrophages and granulo­
cytes to the peritoneum in comparison with normal Lewis rats 
This is perhaps not surprising, since it has been reported 
previously that nude rats do have higher numbers of circulating 
monocytes and granulocytes in peripheral blood ^ Small 
numbers of mature lymphocytes have been reported in nude 
rats,26 this may explain the observation that these animals 
developed a mild, adoptively transferred arthritis Other poten­
tial mechanisms must not, however, be ruled out. and the role of 
the macrophage in adoptively transferred AA. for example, 
remains in question The high mortality incidence of the nudes 
at later time-points could be explained by the housing, since they 
were not maintained under specific pathogen-free conditions 
Interestingly, the data obtained from experimental transfer 
of A A to nude rats contrast with adoptive transfer of EAE, since 
in this model the nude rats were as susceptible as the control 
recipients : Nevertheless, the latter data supports our present 
finding, that a host-derived T-cell population is essential for the 
development of arthritis by adoptive transfer Supporting 
evidence for this hypothesis was obtained by reconstituting the 
nude recipients with 4 χ 10H naive syngeneic spleen cells These 
rats proceeded to develop a more severe arthritis than the non-
rcconsliluted controls 
The cellular interactions responsible for the arlhntogenic 
effect of donor Τ lymphocytes are difficult to understand One 
plausible explanation may be that the passively transferred 
lymphocytes induce anti-idiotypic Τ cells in the host lymphoid 
tissue which are able to migrate specifically to the synovium 
These cells have been reported in vaccination experiments in 
ΕΑΕ,
Ί
" where anti-idiotypic cells were detected in the popliteal 
lymph nodes of rats that had been immuni/ed with MBP-
pnmed lymphocytes An alternative explanation is that trans­
ferred Τ cells may induce the activation of host macrophages 
which then migrate to the joint and initiate lesion development 
The recent observation that AA can be transferred by a 
macrophage-type of synoviocyte supports this hypothesis w 
Macrophage involvement would also explain why nude reci­
pients were seen to develop a mild adoptively transferred AA in 
our experiments Further experiments are clearly required to 
lest these hypotheses 
In conclusion, our experimental data indicate that in the 
'classical1 adoptive transfer, which is primarily mediated by 
cellular immune mechanisms, a host-derived Τ lymphocyte 
population is crucial for arthritis development This is probably 
controlled within draining lymph nodes where the donor Τ 
lymphocytes initiate the host response 
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SUMMARY 
Inbred Temale Lewis (LEW/N) rats develop a severe chronic arthritis in the adjuvant arthritis (AA) 
model, histocompatibie Fisher (F344/N) rats are resistant and germ-free Fishers (GF F344) arc again 
susceptible. In this study we show that the F344 rat can become susceptible lo AA, using 
Mycobacterium tuberculosis (M.tb.) in the powerful adjuvant paraffin oil, instead of mineral oil 
(Freund's incomplete adjuvant (FIA)). This indicates that the F344 rat does not lack Τ effector cells. 
To examine further mechanisms responsible for suppression, we determined the level of plasma 
corticosterone in response to IL-l i in Lewis, F344 and G F F344 rats. IL-l i induced only low 
amounts of corticosterone in Lewis rats, bul high amounts in both F344 and G F F344 rats. The G F 
F344 rats are susceptible to AA, but the severity of the disease is reduced compared with Lewis rats. 
This indicates that corticosterone may be an important mechanism to suppress disease development, 
but not the only mechanism. In addition we investigated whether Τ suppressor cells play a role in the 
resistance of the F344 strain. This was performed by pretreating the animals with the immunomodu-
lating drugs cyclophosphamide (Cy) and cyclosporin A (CsA). Wc were unable to make the F344 rat 
susceptible to AA, indicating that active suppression does not play a role in the induction phase of 
arthritis. This finding is confirmed in adoptive transfer experiments of AA from Lewis to F344 rats. 
Our data suggest the lack of a strong pre-existing suppression in the F344 rats, and indicate that 
suppression is generated upon bacterial challenge. Whether suppression is overruled probably 
depends on the power of adjuvants used and potential control by corticosteroids. 
Keywords adjuvant arthritis susceptibility corticosterone cyclophosphamide 
cyclosporin adoptive transfer 
INTRODUCTION 
Chronic erosive polyarthritis, resembling human rheumatoid 
arthritis, can be induced in susceptible rat strains by several 
bacteria. Two well studied models are the adjuvant arthritis 
(AA) induced by an intradermal immunization of heat-killed 
mycobacteria suspended in mineral oil [I] and the streptococcal 
cell wall (SCW)-induced arthritis, which can be induced by a 
single i.p. injection of a sterile, aqueous suspension of SCW [2]. 
For the AA as well as the SCW-A the susceptibility to arthritis 
seems to be regulated by the bacterial flora. In both models 
Lewis rats are susceptible, the histocompatiblc conventional 
Fisher (CV F344) resistant [3,4]. and the germ-free Fisher (GF 
F344) again susceptible [5,6]. Some research has already been 
performed to explain this difference in susceptibility between the 
Lewis and F344 rat. but with a different underlying mechanism. 
We showed that the F344 rat was unable io mount a marked Τ 
Correspondence: Dr A. G. M. van dc Langerijl. Department of 
Rheumatology. University Hospital Nijmegen. PO Box 9101. 6500 HB 
Nijmegen. The Netherlands. 
cell response against SCW material, and that depletion of Τ 
suppressor cells in vitro led to a restoration of the Τ cell 
proliferative response [7]. This clearly demonstrated that active 
suppression can play an imporant role in the resistance of the 
F344 rat. Interestingly, however, depleting F344 rats in vivo of 
OX8 * cells did not make this strain susceptible to exacerbations 
[8]. In addition. Hogcrvorst et al. [9] also found that in AA 
responsiveness to certain mycobacterial antigen epitopes could 
be related to susceptibility. However, in this study the non-
responsiveness of the F344 appeared not to be due to antigen-
specific suppression. On the other hand. Sternberg et al. showed 
in rivo that the Lewis strain has an impaired corticosterone 
response after an i.p. injection of SCW. and that this defect is 
located in thchypolhalamic-piiuitary-adrenal (ΗΡΑ) axis [10]. 
This finding suggests that the ability to generate high levels of 
plasma corticosterone is the main mechanism to suppress 
disease development. However, the latter daia are not necessar­
ily in agreement with the observation that the G F F344 is 
susceptible. 
We performed this in vivo study to gain more insight into the 
regulation of susceptibility in bacterial-arthritis models. Using 
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the AA model wc investigated which mechanisms play a role in 
the resistance of the F144 rat 
First we investigated whether the resistance of the F144 
strain tan be overruled using more powerful adjuvants 
In addition we examined whether the GF F 144 like the 
Lewis also has an impaired corticosterone response We 
therefore compared the corticosterone responses to the inflam 
matory mediator IL l i in both Lewis F 344 and GF F 344 
Finally we investigated the presence ofactivc suppression in 
CV F144 using prelreatmenl with low-dose cyclophosphamide 
(Cy) or low dose cyclosporin A (CsA) drugs proven to have 
anti-suppressor effects in AA [II 11] and experimental allergic 
encephalomyelitis (EAE) [14 15] Additionally we performed 
adoptive transfer experiments of A A using L ewis A A cells given 
to F344 rats to examine whether the F144 was able to suppress 
disease development when Τ effector cells were passively 
generated 
M A T E R I A L S AND M E T H O D S 
Rats 
Female Lewis rats were originally obtained from the Zentral 
Institut fur Versuchstierzuchl (Hannover Germany) and were 
bred in our own lacilities I emale I 144 rats were also obtained 
Irom the Zentral Institut fur Versuchslier/ucht Germ frec(GF) 
F144 rats were originally obtained from Jackson 1 aboraloncs 
(Bar Harbor ME) and were bred in overpressure isolators in 
our own facilities The isolators and faeces were screened once 
every 2 weeks for bacterial contamination The rats weighed 
between ПО and 180 g at the beginning of each experiment and 
were fed standard food and lap water ad libitum 
induction of adjuianl arthritis 
Arthritis was induced by an intradermal injection at the base of 
the tail with 100 /il of 10 mg ml M\cohacUrtum tuberculosis 
(M tb ) (H37RA Difco Laboratories Ine Detroit MI) sus 
pended in Freund s incomplete adjuvant ( H A Difco) or 
paraffin oil Arthritis was scored macroscopically by measuring 
hind paw thickness with an industrial micrometer One hundred 
per cent of the animals of the experimental groups developed an 
arthritis unless otherwise stated 
In vivo corticosterone measurements 
To diminish the stress caused by the experimental procedures 
each animal was handled daily by the cxperimcnlor for 15 min 
starting I week before decapitation One hour before decapi 
talion animals were injected intraperitoneal^ with 1 /ig ol 
human recombinant IL Ixorsahnc Human recombinant IL lot 
was a generous gift from Dr Ρ Τ Lomedico (Roche Research 
Centre Nutley NJ) After decapitation blood was collected and 
plasma was stored at —20 С for subsequent hormone measure 
ments Briefly this was carried out by extracting the plasma 
corticosterone with 7 5 ml of dichloromclhanc (Baker 
Deventer The Netherlands) The water phase was discarded 
and the dichloromethane phase was evaporated The residue 
was dissolved in 2 ml 0 2"A ethylene-glycol waler(EGW) and 
the concentration of corticosterone in the cluale was measured 
by a radioimmunoassay using an antiserum raised in sheep 
against а В 21 hcmisuccinatc bovine scrum albumin (ВЬА) 
conjugate [16] 
/ 
ι—i—/A-
15 
Days 
Fig 1 Eflect of using dilTercnl oil vehicles on Ihe susceptibility ofinbred 
Lewis M44 and germ free (Ob) F 344 rats for adjuvant arthritis Rats 
were immunized with 1 mg of Mycobacterium tuberculous (M lb ) m 
hreund ^incomplete adjuvant (HA) (a) or l mg of M tb in paraffin od 
(b) (Lewis control received parallin oil alone) Arthritis was measured 
using a calliper and the values represent the sum ofthe thickness of both 
hindpaws±sd (cm) Гасп group consisted of four animals Π Lewis 
о 1-144 • GF F144 · Lewis control 
Drug treatment 
Cy (Endoxan-Asta 100 mg ASTA Pharma AG Frankfurt am 
Main Germany) was dissolved in sterile saline immediately 
before use and injected intravenously asa single dose of 10 25 or 
50 mg kg body weight 2 days before arthritis induction by 
active immunization [11 12] 
CsA (Sandimmune 100 mg ml Sandoz Pharma AG Basel 
Switzerland) was suspended in a I carboxy methyl cellulose 
(CMC) vehicle and given daily per os at a dose of 10 mg kg 
After 1 weeks AA was induced by active immunization as 
described above This protocol was proven to be successful in 
increasing the seventy in Lewis rats (M Bilhngham Lilly 
Research Centre Windlesham LK personal communication) 
Transfer of the adjutant arthritis 
In essence this transfer was performed according to the 
protocol reported by TaurogrVal [17]and Bilhngham eta! [18] 
Briefly draining lymph nodes (inguinal lumbar and popliteal) 
were removed aseptically from rats 10 days alter immunization 
of M tb (125 /ig suspended in 0 05 ml paraffin oil) in all lour 
footpads and tail base After a single cell suspension was made 
the Τ lymphocytes were purified by incubating the cells on a 
nylon wool column (60 mm 17 С) thereby removing the 
adherent cells Τ cells were then stimulated with concanavalm A 
(Con A 0 6 /ig ml) Гог 48 h in RPMI supplemented with 10/, 
fetal calf serum (FCS) 10 mw pyruvate 20 ілм glulamin and 40 
/ig ml gcnlamycin (all Flow I abs Ine McLean VA) Alter 2 
days cells were eentnfuged down and suspended in PBS at a 
concentration of 5 χ 10H cells ml and tn|cclcd intravenously (I 
ml) into naive non irradiated rats The arthritis was measured as 
described above for AA 
R F S U L T S 
Comparison of FIA и ith paraffin od as ι chic le for A A induction 
AA was induced at day 0 in conventional (CV) I ewis CV F144 
a n d i n G F F 1 4 4 using two different oil vehicles FIA or paraffin 
oil Figure lashowsthcrcsultsol f IA as oil vehicle in which all 
CV 1 ewis and 1 4 GF F144 arc susceptible to AA and all CV 
F144 resistant However when paraffin oil was used instead ol 
FIA both Ihe CV Lewis as well as the GF F144 developed a 
more severe arthritis with an earlier onset (Fig lb) Interest 
ingly the CV I 144 also became susceptible to AA withanonset 
around day 14 and an incidence of 100 Lven a suboptimal 
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Fîg. 2. Plasma corticosterone levéis in Lewis (•), F344 (В) and germ-
Ггее (GF) Г.144 (В) rats Rats of cacti strain were injected intraperito-
nealiy with PBS control or Î /ig of human recombinant IL-la. 
Corticosterone was determined in plasma collected 60 min post-
injection. Data shown arc means ¿s.d. of four animals per group. 
Fig. S. Adoptive transfer of adjuvant arthritis to naive Lewis (D>, F344 
(O)and F344 germ-free (GF)(B) recipients. Arthritis was scored as the 
sum of paw thickness of both hind-legs ± s.d. (cm) using a calliper. Each 
point represents the average of 4 5 animals. 
15 20 
Days 
Fig. 3. Fffect of cyclophosphamide on the development of arthritis in 
Lewis {a ) and F344 (b) rats. Cyclophosphamide was given intravenously 
at three different single doses (mg kg body weight) 2 days before 
arthritis induction. Arthritis was scored as the sum of the thickness of 
both hind-legs (cm). F.ach point represents the mean value ± s.d. of four 
animals, (a) D. Lewis control, O, Lewis 10 mg kg;», Lewis 25 mg kg; · , 
Lewis 50 mg kg. (b) a, F344control; O, F344 10 mg kg, • F344 25 mg> 
kg; · . F344 50 mg kg. 
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Fig. 4. Effect of oral cyclosporine A (CsA) pretreatment (10 mg'kg) on 
the development of adjuvant arthritis in Lewis and F344 rats Daily 
treatment was started at day 22 and stopped at day 0. when arthritis 
was induced. Control rats received the vehicle carboxy methyl cellulose 
(CMC) alone. Arthritis was scored as the sum of paw thickness of both 
hind-legs ¿s.d. (cm). F.ach point represents the average of eight animais. 
Data were tested with Student's /-test. *P<0-05. O. Lewis; Ш. Lewis 
CsA; O. L'344; · . F344 CsA. 
dose of M.tb., 0 Ί tng/rat instead of I mg/rat, gave a 100% 
incidence in the CV F344 strain, though less severe (data not 
shown). 
To rule out the possibility that the latter form of arthritis 
induction might be caused by the adjuvant alone, we tried to 
induce arthritis in CV Lewis rats with paraffin oil alone, but 
without success. 
Corticosterone responses to ¡L-la. in CV Lewis, CVF344 and G F 
F344 rats 
Since corticosterone is an important hormone because of its 
ability to suppress disease development, and can therefore have 
great influence on susceptibility to AA, we determined plasma 
corticosterone levels in response to the inflammatory mediator 
IL-lx in Lewis, F344 and G F F344 rats. 
To exclude stress influences on the steroid levels, animals 
were handled daily for 6 days before IL-l challenge. Intraperito-
neal IL-la. 1 h after injection, induced a marked plasma 
corticosterone response in CV F344 rats and only a minimal 
response in CV Lewis (Fig. 2). Interestingly, however, i.p. IL-lar 
induced an identical level of plasma corticosterone in the G F 
F344. compared with the CV F344. 
Since handling of the GF F344 in the above experiment 
occurred outside the isolator, and susceptibility can change into 
resistance due to conventionalization [6,19,20], we checked 
whether the G F F344 rats were still susceptible to AA. 
Therefore, AA was induced in GF F344 rats, which were housed 
for 1 week in the conventional housing facilities. No difference 
in susceptibility was observed between the latter group and the 
GF F344, with a maximum arthritis score of 1-3 + 0-3 and 
1-4 + 0-3, respectively. 
Effect of drug pretreatment and susceptibility to an adoptive 
transfer 
To study whether suppressor cells, already present or generated 
during the induction phase of the arthritis, are responsible for 
suppressing disease development, animals were pretreated with 
low doses of Cy or CsA, drugs proven to have anti-suppressor 
activity [21,22]. 
A single dose of Cy ( 10, 25 or 50 mg kg body weight) was 
injected intravenously 2 days before arthritis induction. In the 
Lewis rat, Cy pretreatment inhibited arthritis development 
dose-dependently (Fig. 3a). In F344 rats none of the doses used 
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was able lo make the F344 susceptible ю АЛ, and even wilh a 
low dose of 10 mg/kg body weight, only one F344 (25%) 
developed an arthritis (Fig. 3b). 
CsA (10 mg/kg body weight) was given orally before 
arthritis induction. In Lewis rats, CsA induced a more severe 
arthritis with an earlier onset, compared with the control rats 
(Fig. 4), which was significant at day 15 (/·<0·05; Student's 1-
test). Again no effect of CsA prelrcalmenl was seen in С V F344. 
It is still possible that suppressor cells were present, but are 
as sensitive to immunosuppressive agents as the arlhritogenic 
cells. We therefore investigated whether it was possible to delect 
any suppressive activity by performing adoptive transfer experi­
ments. As shown in Fig. 5, we were able to induce a chronic 
arthritis by adoptive transfer in the Lewis recipient wilh an onset 
at day 4. Transferring Lewis A A-spccific Τ cells to С V F344 and 
G F F344 rats induced an identical onset and severity in the first 
days in CV Lewis, CV F344 and G F F344. At later time points 
, arthritis declined more rapidly in both F344 strains, which may 
point to generation of suppression at thai stage. However, it can 
not be ruled out thai the latter phenomenon is caused by minor 
histocompatibility differences between Lewis and F344 rats. 
DISCUSSION 
In this study we investigated how the F344 rat may regulate its 
resistance to bacteria-induced arthritis. First, we examined 
whether a lack of Τ effector cells is responsible for the resistance 
ofthe F344 rat. Using a more potent adjuvant, M.lb. in paraffin 
oil, we were able to make the F344 rat susceptible, suggesting 
that ihe F344 rat does not lack Τ effector cells for arthritis 
development, dala which are in agreement with arthritis 
susceptibility in G F F344 rats. Furthermore, this finding 
indicates that neither clonal deletion [23] nor clonal ancrgy [24] 
are the mechanisms by which the F344 regulates ils resistance. 
In addition, we show that Lewis rats injected with paraffin 
oil alone did not develop arthritis, suggesting thai M.lb. is 
essential for arthritis induction. This is in contrast with the 
synthetic adjuvant model [25] or the adjuvant model reported by 
Kleinau el al. [26] and Cannon et al. [27], who were able to 
induce arthritis in DA rats with FIA alone. 
Since a lack of Τ effector cells could not explain the observed 
differences between the Lewis and F344 strains, we investigated 
whether the susceptibility can be explained by impaired cortico­
sterone responses to an inflammatory mediator. As can be seen 
in Fig. 2, the CV F344 rat, resistant to arthritis induction, had 
identical plasma corticosterone levels in response lo IL- la to the 
susceptible G F F344. The latter G F rats developed, however, an 
arthritis of lower severity compared with the one in Lewis rats 
(Fig. la). This suggests that the ability to generate high levels of 
corticosterone is an important mechanism of the F344 lo 
suppress arthritis development, but leaving other mechanisms 
as important for the regulation of resistance. 
Another likely candidate may be active suppression, espe­
cially since it was shown in in vitro studies in the SCW-induccd 
arthritis model, that an impaired Τ cell proliferative response to 
the bacterial antigen could be restored by depleting CDS* Τ 
cells [7]. We were therefore interested to see if we could delect 
any in viro suppressor activity in the CV F344 rat. 
This was first examined by prelreating ihe animals with low-
dose Cy or low CsA. both drugs which have been shown in vivo 
to operate on the level of Τ cells, especially on Τ suppressor cells 
[21,22]. In the case of low dose Cy prctrcalmcnt in the Lewis 
strain, we only saw a decrease in arthritis severity, suggesting 
lhat even low dose Cy not only acts at the level of Τ suppressor 
cells but also at the level of Τ effector cells. This suppressive 
effect seen in Lewis can very well explain why we did not see any 
effect in the F344 strain. Earlier data with Cy prelrcalmenl also 
show a dose-dependent effect. Low dose pretreatmeni enhanced 
the severity of A A in the WKA strain [I I] and made the resistant 
Buffalo strain susceptible lo AA [12], while a higher dose 
suppressed AA in the susceptible Hollzman and susceptible 
PVG/c strain [28]. Interestingly, low dose Cy also suppressed 
AA development in Ihe susceptible Holtzman strain. This set of 
data is at variance with our results, and indicates that the net 
effect of Cy pretreatmeni may be strain-dependent. Further­
more, timing of administration is also of importance, since 20 
mg/kg Cy given on days 0-2 after adjuvant prevented the 
development of arthritis in Sprague Dawley rais [29]. There­
fore, treatments at laler lime points are nol useful for studying 
the role of Τ suppressor cells in the F344. Because we were not 
able to detect any Τ suppressor activity in the F344 rat or 
increase in the severity of arthritis in the Lewis rat, we decided to 
lest CsA pretreatment. The latler was proven to increase the 
severity in Lewis rats (M. Billingham, Lilly Research Centre, 
Windlcsham, UK; personal communication) and therefore may 
be more effective for testing whether preexisting Τ suppressor 
cells are also responsible for the resistance ofthe F344 rat. 
Indeed, CsA prelrealmcnt was able to increase the severity in 
the Lewis strain, data which are in agreement with low-dose 
CsA pretreatmeni (2 or 4 mg/kg on alternate days for 22 days) in 
E AE [ 13]. However, the F344 rat still did nol become susceptible 
to AA, indicating that either the level of suppression was loo 
high to down-regulate, or the Τ suppressor activity, present 
during the induction phase of arthritis, docs not play a role in 
the regulation of resistance in the F344 strain. Since CsA 
pretrcatmem primarily eliminates the preexisting Τ suppressor 
cells and hardly affects Τ suppressor cells generated during the 
onset of disease, the latter may still maintain the resistance ofthe 
F344. Some evidence for this up-rcgulation has been found by 
Kingston el al. (Lilly Research Centre, unpublished results), 
who found by phenotypic analysis lhat in A A in both Lewis and 
F344 rats CD8 ' cell numbers are i ncreased. and that in the F344 
strain ihe numbers of these cells remain elevated. This is in 
contrast to the Lewis strain, where C D 8 f cells decline as disease 
progresses. 
Unfortunately CsA treatment at later time points, lo 
eliminate these up-regulated Τ suppressor cells, is of limited use. 
since it has been frequently shown that this results in a 
suppression in several arthritis models [30-33]. 
Additional indications lhat the F344 ral has to up-regulalc 
ils suppressor activity were found in adoptive transfer experi­
ments, since the F344 strain was susceptible in the transfer 
system. Because Lewis and F344 strains are reported to be 
syngeneic at the RT-1 A and RT-1 В region ofthe MHC region, 
and only differ wilh respect to minor histocompatibility antigens 
[34], we assumed thai grafl-trrmv-host reactions would not 
occur in ihese adoptive transfer experiments. Interestingly, the 
arthritis declined rapidly in both the CV and the G F F344 (Fig. 
5), which can be explained by either the generation ofsuppres-
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sion or by e l iminat ion οΓ the transferred Lewis cells d u e t o 
m i n o r his tocompat ib i l i ty differences W e have found several 
indicat ions which d o s u p p o r t the latter p h e n o m e n o n e g n o 
increase in the c h r o n i u t v when the F144 recipient w a s pre-
trcatcd with low dose of Cy before the a d o p t i v e transfer a n d 
high responses in a mixed l y m p h o c y t e assa\ of Τ t e l k f rom a n 
F 1 4 4 recipient p r i m e d with Lewis Τ cells ( m a n u s c r i p t in 
p r e p a r a t i o n ) 
O f course wc considered s tudy ing the presence of active 
suppress ion in the F W by m mo t r e a t m e n t with O X 8 
(anl i supprcssor cytotoxic T) H o w e v e r several s tudies in AA 
[IS 16] E A E [17 18] a n d a n exacerbat ion sludv with S C W 
fragments in t h e F 1 4 4 rat [8] have shown n o effect of m Í H O C D 8 
deplet ion indicating that this cell type plays no major role in the 
immunoregu la l ion of AA I n c o n t r a s i in the S C W - A model in 
Lewis ra ts an increase in the seventy and an earlier onset of 
disease were found (day 14 in the cont ro l g r o u p u n w v d a y 5 in 
the O X 8 treated g roup) However the latter results a rc h a rd to 
interpret since this acute phase is considered to be Τ ccll-
i n d e p c n d c n t [19] T h e fact t h a t most studies d o not show any 
effect of this O X 8 t r e a t m e n t d o c s not m e a n thai Τ cells a re not 
capable o f m a i n t a i n i n g resistance o r d o w n regulat ing inflam­
m a t i o n It has been shown t h r o u g h analysis of m u r i n e Πι cell 
lines that C D 4 Τ cells can be classified into T h 1 a n d T h 2 lines 
based on the expression ol l L - 2 a n d i n t c r f c r o n - g a m m a ( I F N - , > 
or I L 4 I L S II -6 and IL-IO respectively [40] Because these 
two types of Τ helper cells synthesi/c l y m p h o k i n e s with 
p r o f o u n d l y different functions it is possible that m (no these 
C D 4 Τ cells may also be i m p o r t a n t regula tors in the resistance 
of t h e F 1 4 4 strain [41] 
T a k e n together these d a t a indicate that t h e F W r a t d o c s 
not lack Τ effector cells for a r thr i t i s d e v e l o p m e n t a n d that the 
i m m u n e system of the F 1 4 4 is also u n d e r c o n t r o l of a del icate 
b a l a n c c o f reactivity a n d suppress ion F u r t h e r m o r e we confirm 
t h a t the ability lo generate high levels ol c o r t i c o s t e r o n e m a v be 
a n i m p o r t a n t m e c h a n i s m of the F144 to suppress disease 
d e v e l o p m e n t H o w e v e r since we l o u n d identical levels in b o t h 
CV and G F F344 rats this leaves o t h e r m e c h a n i s m s like 
bacterial flora as i m p o r t a n t for the regulat ion of resistance to 
AA Wc c a n n o t exclude the possibility that differences d o exist 
in the kinetics of steroid levels in response to IL- la T h e r e l o r c 
l ime course exper iments o f s le ro id levels in c a n n u l a t c d F 1 4 4 a n d 
O F F 1 4 4 rats a r c now in progress after I L - l a chal lenge a n d 
d u r i n g ar thr i t i s d e v e l o p m e n t Finally wc have found clear 
evidence that preexisting aclivc suppress ion d o c s n o t play a role 
in the resistance of the F144 W c a s s u m e thai if any Τ s u p p r e s s o r 
m e c h a n i s m does cxisl ihc F144 needs to up-regulale this u p o n 
bacterial chal lenge U n f o r t u n a t e l y we were u n a b l e t o prove the 
lat ter in a d o p t i v e transfer exper iments since wc l o u n d several 
indicat ions that Lewis Τ cells a re e l iminated in the F144 d u e t o 
minoi histocompatibi l i ty a n t i g e n s 
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SUMMARY 
Previous studies on the regulation ofbaclenal-induced arthritis in rats have focused on endocrine 
aspects as well as differences in Τ cell immunity against bacterial epitopes We analysed the role ol 
both adrenal activity and bacterial flora in determining susceptibility to bacterial-induced arthritis 
Out bred Wislar rats show a low incidence of adjuvant arthntis Moderate sensitivity to adjuvant 
arthritis was found in a selected stress resistant line of the Wistar rat, whereas no arthritis was 
found in a stress-susceplible Wistar line Plasma corticosterone responses after IL-1« exposure 
were however, identical in these two lines, excluding a direct correlation between susceptibility 
and corticosterone levels In line with previous findings in germ-free (GF) F344 rats, GF Wistars 
also appeared highly susceptible to arthritis We further analysed the corticosterone responses in 
GF and conventional (CV) rats Administration of IL-lr* induced identical corticosterone 
responses in both CV and G r F444 rats In addition plasma corticosterone levels were measured 
around the time of onset of arthritis Whereas no rise was seen in the arthritis-resistant CV rats, a 
significant increase was observed from day 14 in GF rats, at the moment of onset of arthritis 
Although this corticosterone response was insufficient to prevent arthritis, it may have ameliorated 
disease expression in the GF F344 rats Our data indicate that the bacterial flora, and therefore Τ 
cell tolerance, is of prime importance in determining susceptibility, whereas the activity of the 
hypothalamus pituitary adrenal (ΗΡΑ) axis may modulate disease seventy 
Keywords adjuvant arthritis susceptibility corticosterone bacterial flora 
INTRODUCTION 
Chronic erosive polyarthritis like adjuvant arthritis (AA) [1] 
and streptococcal cell wall (SCW)-induced arthritis [2], can be 
induced in susceptible rat strains Several investigators have 
examined mechanisms which determine the susceptibility for 
this type of joint inflammation It was found that susceptibility 
is strain dependent and appears to be controlled by an auto­
somal dominant gene locus linked to the MHC [4,4] 
Not only genetic factors but also factors like the bacterial 
flora seem to regulate susceptibility to AA For example, Lewis 
rats are highly susceptible, while the biocompatible Ы44 rat 
is resistant and the germ free (GF) F144 rat is again susceptible 
[5 6] We showed that the ability to generate tolerance deter­
mines susceptibility since only the susceptible Lewis rats were 
able to mount a specific Τ cell response against the injected 
bacteria [6 7] Furthermore, Wilder and co workers showed 
that the Lewis strain has a deficient response of hypothalamic 
Correspondence Dr A G M van de Langerijt Department of 
Rheumaiolog) University Hospital Nijmegen PO Box 9101 6500 HB 
Nijmegen The Netherlands 
corticotropin releasing hormone (CRH) to various stressful 
inflammatory stimuli, while the F344 strain responded in a 
more robust manner [8] As a result the Lewis strain showed a 
deficient response ol plasma corticosterone to these stimuli [9] 
and it was postulated that this diminished response of the 
hypothalamus pituitary-adrenal (ΗΡΑ) axis plays a role in 
determining the susceptibility in the Lewis and F344 strains 
In contrast to the Lewis stram, F344 rats display aggressive 
and stressful behaviour Recently two pharmacogenctically 
selected Wistar lines have been described which seem to 
differ in their neurochemical and neurobiology I organiza­
tion behaviour the apomorphine susceptible (APO-SUS) and 
apomorphine unsusceptible (APO-UNSUS) lines [10] The 
APO-UNSUS rats exhibit a decreased general locomotor 
activity and are less reactive to stressful stimuli than the 
APO-SUS animals [10,11] Of interest, the APO-UNSUS rat 
showed enhanced susceptibility to experimental autoimmune 
encephalomyelitis (EAE) [11] 
To examiné the relati\e importance of the neuroendocrine 
and immune system, we compared the susceptibility to AA in 
the ou I bred conventional (CV) and GF Wistar rais, as well as in 
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the APO-SUS and APO-UNSUS lines Moreover, we deter­
mined plasma level;» of corticosterone after IL-lo injection or 
during arthritis in ine selected Wislar lines and in CV and GF 
Ρ 344 rats 
MATERIALS AND METHODS 
Animals 
Pharmacogenetically selected F14 offspring female Wislar rais 
(APO-SUS and APO-UNSUS) were obtained from the Depart­
ment of Psychoneuropharmacology Selection was made on 
their gnawing response to the dopamine receptor agonist 
apomorphme as described by Cools et al [10] Rats with 
gnawing responses < 10/45 mm were designated as apomor­
phme unsusceptible (APO-UNSUS), and rats with gnawing 
responses > 500 45 mm were called apomorphme susceptible 
(APO SUS) Retention of genetic selection was tested in rats of 
the hrst litter of each generation At the age of 60 days these rats 
were injected with apomorphme and tested as described earlier 
[10] APO-UNSUS rats with the lowest scores and APO-SUS 
rats with the highest scores were selected and used for subse­
quent development of the next generation Rats of the second 
and third litter of each generation were used for experiments 
Female CV outbred Wistar rats were obtained from Harlan 
CPB (Zeist. The Netherlands) and female CV inbred F344 rats 
from the Zentral Institut fur Versuchlierzutht (Hannover. 
German)) Female Lewis rats were bred in our own facilities 
and were originally obtained from the Zentral Institut fur 
Versuchtier¿uehl 
Female Gl· F344 rats were originally obtained from Jack-
son Laboratories (Bar Harbor. Mb), and female GF Wistar 
rats from the Zentral Institut fur Versuchtierzucht and both 
were bred in our own facilities (Central Animal Laboratory) in 
overpressure isolators The isolators and faeces were screened 
once every 2 weeks for bacterial contamination 
The rats weighed between 140 and 180 g at the beginning ol 
each experiment and were housed in rooms illuminated from 
6 0 0 a m t o 6 0 0 p m Standard food and tap water were given 
ad libitum 
Induction of adfuxant arthritis 
Arthritis was induced by an intradermal injection at the base of 
the tail with 100/tl of lOmg ml Mycobacterium tuberculosis 
(H37RA Dilu> Labs, Detroit, Ml) suspended in Freund's 
incomplete adjuvant (HA. Difco) Arthritis was scored by 
measuring hind paw thickness with an industrial micrometer 
In addition, in some experiments we performed a visual scoring 
on both hind and fore feet on the basis oí 0 - no signs of 
redness or swelling, I - mild swelling and redness 2 — severe 
swelling and redness 
In vivo cannulation experiments 
In order to determine plasma corticosterone levels in response 
to administration of IL-lrï or during AA, blood was collected 
from freely moving rats by means of a chronic cannula 
Cannulation of the rats was performed according lo the 
technique described by Steffens (12] with some minor modi-
fications as described by Sweep et al [13] After cannulation, 
the animals were housed individually and handled daily by the 
experimenter to diminish stress caused by the experimental 
procedures 
Animals were allowed to recover from the operation for at 
least 6 days At the start of the experiment, a polyethylene 
cannula was attached to the stainless steel tube on the skull of 
the head Two hours later time course experiments were started 
(t = 0 mm) b> injection of 1/ig of IL-l« intravenously 
Recombinant human IL-1л was a generous gift from Dr 
Ρ Τ LomediLo (Roche Research Centre Nutley NJ) Control 
rats received saline alone At every time point 300 μ\ blood were 
collected for corticosterone measurements, and subsequently 
300 μ\ of saline were returned to the animal Regarding the time 
course experiments in AA. blood withdrawal always started 
around 11 00 a m , to exclude differences in corticosterone 
levels due to the arcadian rhythm 
In vitro corticosterone measurements 
Blood samples were collected in dry lithium-hepann lubes and 
centrifuged at 1500 jç for 10 mm at 4 С Plasma was separated 
and stored at -20 С until assayed 
Corticosterone measurements were performed as described 
by Sweep et al [13] Briefly, plasma corticosterone was 
extracted with 7 5 ml of dichloromelhane (Baker, Deventer, 
The Netherlands) The water phase was discarded and the 
dichloromcthane phase was evaporated The residue was dis­
solved in 2 ml 0 2% ethylene glycol water (FGW). and the 
concentration of corticosterone in theeluate was measured by a 
radioimmunoassay using an antiserum raised in sheep against a 
В-21-hemisuccinale bovine serum albumin (BSA) conjugate 
The sensitivity of the assay was 25 45 fmol lube Theintra-
and interassay coefficients of variation were 5% and 8%. 
respectively 
Statistical anai\ sis 
In the arthritis susceptibility experiments, the hind paw thick­
ness between the different groups was compared by the 
Wilcoxon rank sum test The -y1 test with Yates correction 
was used to analyse the results of the visual scoring 
All corticosterone data are presented as the mean ± s d of 
five to eight animals Comparisons between the corticosterone 
levels in the arthritis experiments were made by the ANOVA 
test with repeated measurements Only when the ANOVA 
revealed a significant difference between both groups were 
values at specific time points further evaluated by Student's t-
test lor unpaired observations 
RESULTS 
Susceptibilit\ of the different Wistar rat lines for AA 
AA was induced in the APO-SUS and APO-UNSUS Wistar rat 
lines, and the incidence and seventy of AA was compared with 
observations in CV and GF Wistar rats All APO-SUS rats 
were resistant, while 10 out of 16 APO-LNSUS rats appeared 
to be susceptible for AA (/> - 0 0001, \ : test) (Tabic I) When 
we measured the paw thickness only a moderate increase was 
noted in the APO-UNSUS rats, with a late onset (Fig 1) 
The susceptibility of the CV Wislar rats, compared with the 
APO-SUS and APO-UNSUS rats appeared to be intermediate 
(3 out of 14) On the other hand, almost all the GF Wistar rais 
were susceptible for AA, and developed a severe and chronic 
joml inflammation (Fig 1,* Ρ = 0 0001 xenus CV Wistar rats. 
Wilcoxon rank sum test) 
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Factors determining the susceptibility to AA 
ТіЫе 1. Clinical expression of adjuvant arlhmis 
( AA) in the different Wisiar rats after the induction 
of AA 
ЛРО-SUS 
APO-UNSUS 
CV Wistar 
OF Wisiar 
0 
16 
6 
I I 
1 
1 
-
6 
3 
4 
2 
4 
-
6 
The seventy ofarihritis was scored visually on 
a scale of 0-2: 0 = no redness or swelling; 
1 — mild swelling and redness; 2 — severe swel­
ling and redness The data shown are the number 
of animals belonging to each group, 20 days after 
induction of arthritis. The susceptibility to AA 
between apomorphine susceptible (APO-SUS) 
and apomorphine unsusceptible (APO-UNSUS) 
was significantly different (P - 00001, \2 test). 
Corticosterone levels after ¡L-la injection in APO-SUS and 
APO-LWS US rat lines 
We analysed the effect of IL-1л injection on plasma corticos­
terone levels in both APO-SUS and A P O - U N S U S rats. This 
proinflammatory cytokine is able to stimulate the Η Ρ Α axis, 
resulting in an increased plasma concentration of the anti­
inflammatory steroid hormone corticosterone. 
Intravenous (i.v.) injection of 1 /ig I L - Ι α in cannulaled 
APO-SUS and A P O - U N S U S rats resulted in an increase of 
plasma corticosterone levels at 30 min (Fig. 2). N o significant 
dinerences could be detected between corticosterone levels in 
the APO-SUS and A P O - U N S U S rats. Corticosterone levels in 
control animals, injected with saline alone, remained low 
throughout the entire experiment. 
Corticosterone levels after AA induction in Wistar rat lines 
We examined corticosterone levels after the induction of AA in 
cannulaled APO-SUS and A P O - U N S U S rats. As shown in 
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Fig. 2. Plasma corticosterone levels in apomorphine susceptible (APO-
SUS) ( · ) and apomorphine unsusceptible (APO-UNSUS) (•) rats after 
i.v. injection of I ng of recombinant human IL-lo (closed symbols) at 
r — 0 min. Each time point represents the mean ± s.d. of eight animals. 
The control groups received saline alone (open symbols). 
Fig. 3, no significant differences could be detected in plasma 
corticosterone between these two different rat lines (ANOVA, 
days 15, 18,21). 
Susceptibility to AA in Lewis. CV F344 and GF F344 rats 
It is known from previous studies that G F F344 rats are highly 
susceptible, whereas CV F344 are resistant to bacterial arthri­
tis. We analysed the corticosterone response in these rats, both 
after 1L-1 exposure and after induction of AA. Figure 4 shows 
the difference in AA susceptibility between the CV and G F 
F344 rats in this set of experiments. For comparison, data from 
Lewis rats are also given. 
Corticosterone levels after IL-ft* injection in F344 rats 
The corticosterone response after i.v. injection of I L - Ι α was 
similar in CV and G F F344 rats (Fig. 5). Of interest, the peak 
levels were twice as high in F344 rats as in Wisiar rats (Fig. 2). 
The control animals, injected with saline alone, showed no 
increase in plasma corticosterone. 
••
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Fig. 1. Susceptibility of the same Wistar rats as shown in Table 1. but 
now scored by measuring the hind paw thickness with an industrial 
micrometer. Values represent the mean ± s.d. of 11 16 rats per group. 
The germfrec (GF) Wistar rats (n) were significantly more susceptible 
than the conventional (CV) Wistar rats (o) • Ρ = 0 0001. Wilcoxon 
rank sum test. · , Apomorphine susceptible (APO-SUS); •, apomor­
phine unsusceptible (APO-UNSUS). 
1200 
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5 •--
Flg. 3. Plasma corticosterone levels in apomorphine susceptible (APO-
SUS) ( · ) and apomorphine unsusceptible (APO-UNSUS) (•> rats after 
induction of adjuvant arthritis (AA) at day 0 Blood samples were 
collected at 11:00 a.m. Values represent the mean ± s.d. of five animals 
per group. ANOVA (days 15, 18, 21) revealed no significant di (Terence 
between both groups. 
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Fîg. 4. Different susceptibility of Lewis (о), conventional (CV) F344 (•) 
and germ-free (GF) F344 ( · ) rais to the induction of adjuvant arthritis 
(AA). The arthritis was scored by measuring the hind paw thickness 
with an industrial micrometer. The values represent the mean ± s.d. of 
four animals per group 
Corticosterone levels after induction of A A in F344 rats 
Finally, we analysed the course of corticosterone responses 
after immunization and during the onset of AA in F344 rats. 
Figure 6 shows that plasma corticosterone levels remained low 
in the resistant CV F344 rats during the whole period of 
observation. Compared with the CV F344, a significant 
increase (ANOVA Ρ < 0-01, days 14, 18, 21) in corticosterone 
levels was observed during the onset of AA in the GF F344 rats 
(day 18; · Ρ < 0 05, Student's i-test). 
DISCUSSION 
There is now increasing evidence that not only the genetic 
background, but also the bacterial flora and neuroendocrine 
system determine the overall immune response ofan individual. 
In this study we analysed the relative importance of the activity 
of the ΗΡΑ axis and the bacterial flora in determining suscept­
ibility to AA. 
The observation that the stress-susceptible APO-SUS 
Wistar rats were significantly less susceptible to AA than the 
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Fig. 5. Plasma corticosterone levels in conventional (CV) (•) and germ-
free (GF) F344 (Φ) rais after the injection of 1 /ig IL-la intravenously 
at t — 0 mm (closed symbols). Values represent the mean ± s.d. of six to 
eight animals per group. The control groups received saline alone (open 
symbols). 
Days 
Fig. 6. Plasma corticosterone levels in conventional (CV) (a) and germ-
free (GF) F344 ( # ) rats after the induction of adjuvant arthritis (AA). 
Blood samples were collected at 11:00 a.m. Values represent the mean ± 
s.d. of six animals per group. ANOVA revealed a statistically significant 
difference for both groups (days 14, 18. 21). day 18 * Ρ < 005, 
Student's Mest. 
s tress-resistant APO-UNSUS rats is in agreement with recent 
findings in the EAE model [11], although the differences 
appeared to be more pronounced in the latter model. These 
findings suggest that different types of behavioural and neu­
roendocrinological responses to stress are correlated to differ­
ent susceptibility to AA. Although we may not conclude that 
there is a causal relationship between stress and susceptibility to 
AA, several other data do indicate that stress can affect 
susceptibility. For instance, it has been observed that suscept­
ibility to EAE can be partially suppressed by environmental 
stress [14]. Similarly, we observed that stress, induced by daily 
injection of a vehicle substance, may result in almost complete 
prevention of murine type II collagen arthritis ([15]. manuscript 
in preparation). In addition, studies in patients with rheuma­
toid arthritis (RA) also demonstrated immunosuppressive 
effects of stress [16,17]. In contrast, other investigators empha­
size that stress may selectively affect the Τ suppressor cell 
system in RA patients [18]. 
Interestingly, very recently differences were observed in Τ 
cell responsiveness between APO-SUS and APO-UNSUS rats 
(A. Kavelaars et al., m a nu sen pi in preparation). It appeared 
that lymphocytes from APO-SUS rats had an increased mito­
gen reactivity and a higher number of natural killer (NK.) and Τ 
suppressor/cytotoxic cells than lymphocytes from APO-
UNSUS rats. 
The fact that CV outbred Wistar rats show intermediate 
susceptibility [19], compared with the APO-SUS and APO-
UNSUS rats, fits in with the fact that the APO-SUS and APO-
UNSUS rats represent extremes in an unselected population of 
rats [10]. Furthermore, the observation that the GF Wistar rats 
were highly susceptible suggests that the bacterial flora seem to 
be extremely important in determining susceptibility to AA. 
This is in line with several previous studies, in which it was 
demonstrated that GF* F344 rats were susceptible to bacterial-
induced arthritis [5,6] and that conventionalization of these GF 
rats could dramatically moderate disease severity [6,20]. 
Analysis of corticosterone levels in response to administra­
tion of IL-lo showed that the genetic background can deter­
mine the activity of the ΗΡΑ axis, since we observed a twice as 
high corticosterone response in the F344 rats compared with 
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the Wistar rats Interestingly all the time course experiments 
with IL 1« showed identical total corticosterone levels between 
the Wistar rat lines and between the CV and Gb Ь344 strains 
This suggests that the activity of the ΗΡΑ axis does not 
determine the susceptibility to AA in these d ι (Teren l rats 
These data support our previous findings [21] but are in 
contrast with the findings tn the susceptible CV Lewis rats 
[8 9] in which a clear defect of the ΗΡΑ axis was observed 
Furthermore a recent study showed that RA patients may also 
have an abnormal ΗΡΑ axis response to stress [22] On the 
other hand we can not totally exclude that differences in 
plasma steroid hormone levels may still determine susceptibil 
ily since we did not discriminate between free corticosterone 
and carrier bound corticosterone Regarding this Rots t/ a/ 
[24] also observed no differences in total corticosterone levels 
when the same Wistar rat lines were exposed to a novel 
environment as stress stimulus However when they compared 
free corticosterone as well as adrenocorticotropic hormone 
levels they were then able to show a small increase in the ΗΡΑ 
axis activus of the APO SUS rats 
Analysis of the corticosterone levels after AA induction 
showed no significant differences between the APO SUS and 
APO UNSUS rats over a broad time span This hnding 
parallels the only minor differences in arthritis severity 
between these two rat lines In the Gl· Ы44 rats however 
we were able to delect a significant increase in corticosterone 
levels after the onset ol arthritis This increase may be due to 
the stress of the disease itselt The latter phenomenon has also 
been observed during the onset of the clinical signs of FAE in 
the Lewis rat [24 25] On the other hand a recent report in AA 
shows increased levels of plasma corticosterone al read ν at day 7 
after immunization in Sprague Dawley rats [26) At that time 
point there were still no clinical signs of arthritis The difference 
might be explained by the fact that the ΗΡΑ axis responsiveness 
during chronic stress is strain dependent 
Finally no increase in corticosterone levels was observed in 
the resistant CV F344 rats which suggesls that resístante of the 
Γ344 strain can not be explained by an increased ΗΡΑ axis 
activity This indicates that the arthntogenic responses are 
probably controlled at another level A likely candidate is Τ 
cell tolerance especially in the light of our previous findings in 
which we were able lo delect a correlation between Τ cell 
responses and susceptibility [6 7] On the other hand we can 
nol exclude that the adrenal response in the С V F344 rats may 
only increase just after immunization (between days 0 and 7) 
and in this way directs the immune response to either suppres 
Sion or reactivity However this is not very likely since an 
adrenalectomy study in the EAE model showed that corticos 
terone only had an important regulatory role just before Ihe 
clinical onset of LAE in the susceptible Lewis strain [24] as well 
as in Ihe resistant PVG strain [27] 
In conclusion our data indicate that differences in beh a 
vioural and neuroendocrinological responses to stressors are 
correlated to differences in susceptibility to bacterial arthritis 
However the bacterial flora seem far more important in 
regulating susceptibility I urlhermore the corticosterone data 
suggest lhat the ΗΡΑ axis actmt) correlates with disease 
sevenl) instead of being a mechanism to prevent disease 
Analysis of free corticosterone levels in the different suscepti 
ble rais and lymphocyte proliferation assays is now in progress 
These experiments will provide further insight into the relative 
importance of steroid hormone levels and Τ cell tolerance in 
susceptibility to bacterial!) induced arthritis 
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CHAPTER 7 
Role of ß2 integrine in the recruitment of phagocytic cells in joint 
inflammation in the rat 
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Adhesion molecules of the ß2 family of integrine play an 
important role in adhesion and migration of leukocytes to 
inflammatory sites. Several in vivo studies indicate that not 
only monoclonal antibodies (mAbs) directed against the 
common β subumt (CD18) but also to the individual α sub-
units (CDlla, CDllb) can effectively inhibit different types 
of inflammation. In this study we report that in the adjuvant 
arthritis (AA) aCDlla, aCDllb, or even aCDlS treatment 
could not prevent disease development. Moreover, we exam­
ined the same mAbs in an acute nonspecific inflammation at 
different sites in the rat. We found that pretreatment with 
aCUlla or aCDllb could significantly block a zymosan peri­
tonitis, but appeared to have no effect on a locally induced 
joint or dermal inflammation Interestingly, aCD18 treat­
ment, which blocks the entire CD11/CD18 complex, was able 
to inhibit the influx of inflammatory cells in a peritonitis as 
well as in a joint and dermal inflammation These data not 
only indicate that the type of joint inflammation determines 
which adhesion molecules play a role in transendothelial 
migration, but also that involvement of the β2 integrine is 
highly site specific, о mi лехйтк pn·» i«c 
INTRODUCTION 
The process of adhesion and transendothelial migra­
tion of leukocytes plays an important role in the onset 
of inflammatory reactions Adhesion molecules in­
volved in the attachment to the vascular endothelium 
comprise the integrine, a group of receptors containing 
several subfamilies (1) The CD11/CD18 complex be­
longs to the β2 subfamily of integrine and has three 
members with distinct α chains, C D l l a , CDl lb, and 
CDllc, and a common noncovalently bound identical β 
chain, CD18 C D l l a / C D 1 8 (LFA-1), CDllb/CD18 
(CR3), and CD11C/CD18 (pl50,95) are expressed on 
monocytes and granulocytes, whereas C D l l a is also 
expressed on В and Τ lymphocytes (1, 2) 
At present, monoclonal antibodies (mAbs) are avail­
able, which are directed specifically against CD18, 
CDl la, C D l l b , or their hgand, the intercellular adhe­
sion molecule-1 (ICAM-1) This makes it possible to 
examine the role of the different adhesion molecules in 
inflammatory models, like joint inflammation Lately, 
several m vwo studies have tested the effects of these 
mAbs in different types of joint inflammation Pretreat­
ment with anti-CDl8 (aCD18) could inhibit the influx 
of polymorphonuclear cells (PMN) to an IL-8-induced 
joint inflammation (3), whereas both aICAM-1 as well 
as o C D l l a are able to suppress a peptidoglycan/ 
muramyl dipeptide-induced arthritis (4) Furthermore, 
treatment with aCD18 not only inhibited the initial 
influx of inflammatory cells in the acute phase, but also 
resulted in an amelioration of the chronic phase of an 
antigen-induced arthritis (5) 
Finally, it has been shown that adjuvant arthritis 
(AA) can be suppressed with aICAM-1 (6) and colla­
gen-induced arthritis with either aICAM-1 or a C D l l 
(4) However, in the latter studies treatment was 
started early and also affected the generation of cell-
mediated immunity against the injected antigen 
Therefore, it is hard to determine whether these mAbs 
selectively interfered with the migratory processes of 
inflammatory cells to the joint Of interest, the migra­
tion of PMNs to the AA joint seems to be mediated 
through C D l l a , whereas Τ cells appear to use CDlla/ 
CDllb-independent mechanisms (7) 
The aim of the present study was twofold First, we 
investigated whether different adhesion molecules in 
the joint may be utilized for leukocyte migration, de­
pending on the type of inflammation Second, we in­
vestigated whether the joint differs from other sites in 
the body with respect to the type of adhesion molecules 
used during inflammation We first analyzed whether 
the onset of AA can be prevented by blocking the mi­
gratory processes with mAbs against C D l l a , C D l l b , 
or all the β2 integrine This chronic joint disease can be 
induced in Lewis rats by immunization with heat-
killed Mycobacterium tuberculosis in Freund's incom­
plete adjuvant (FIA) (8) Moreover, we examined the 
effects of pretreatment with the same mAbs in an 
acute, nonspecific inflammation For this purpose, zy­
mosan was injected in the joint, peritoneum, or derm 
It was found that none of the mAbs prevented the 
onset of AA Furthermore, pretreatment with a C D l l a 
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or otCDllb only inhibited the migration of phagocytes 
to an inflamed peritoneum but not toward an inflamed 
joint or dermal inflammation In contrast, treatment 
with aCD18 was able to block effectively, independent 
of the site of inflammation 
MATERIALS AND METHODS 
Animals 
Lewis rats were originally obtained from the Zentral 
Institut fur Versuchstierzucht (Hannover, FRG) and 
were bred in our own facilities Rats weighed 160-220 
g at the start of the experiments and were fed tap water 
and standard chow ad libitum 
mAb Production and Treatment 
Hybndomas secreting aCD18 (WT-3, mouse IgGl), 
aCDlla (WT-1, mouse IgG2a) (9), both a kind gift from 
Dr M Miyasaka, or aCDllb (ED7, mouse IgGl) (10) 
were used to produce ascites fluid in BALB/C rnulrnu 
mice by standard methods mAbs were purified using 
protein G-Sepharose CL-4B (Pharmacia LKB, Upp­
sala, Sweden) and stored at 4°C in saline (4 mg/ml) 
The control group received BOM22 (mouse IgGl anti-
human CD74), kindly provided by Dr WA Allebes 
(11) Rats were injected intravenously (ι ν ) into the 
tail vein 
Induction ofAA 
To induce AA, female Lewis rats were immunized 
intradermally at the base of the tail with 100 μΐ of 10 
mg/ml M tuberculosis (H37RA, Difco Laboratories, 
Ine , Detroit, MI) suspended in FIA (Difco) The arthri­
tis was scored macroscopically by measuring hind paw 
thickness with an industrial micrometer At the end of 
the experiment ankle joints were removed and the 
level of inflammation was determined by histology 
Induction of Sterile Peritonitis 
To induce sterile peritonitis, male or female Lewis 
rats were injected intraperitoneally (ι ρ ) with 5 mg 
zymosan (Sigma, St Louis, MO) dissolved in 2 or 4 ml 
of saline After 18 hr rats were sacrificed and the peri­
toneal cavity was washed once with 40 ml saline The 
isolated peritoneal cells were washed and counted in a 
Coulter counter Differential leukocyte counts of the 
peritoneal cells were determined morphologically us­
ing Wright Giemsa stained cytospin preparations At 
least 200 nucleated cells were counted per preparation 
Induction of Unilateral Joint Inflammation 
A nonspecific unilateral joint inflammation was in­
duced by injecting either 0 2 or 0 6 mg zymosan in 60 
μΐ phosphate-buffered saline (PBS) into the right knee 
joint of female Lewis rats As a control, 60 μΐ PBS was 
injected into the left knee joint of the same animal 
After 24 hr animals were sacrificed and the seventy of 
arthritis was determined by histology 
Induction of Intradermal Inflammation 
A unilateral intradermal inflammation was induced 
by injecting 40 μg zymosan in 10 μ.1 PBS into the pinna 
of the right ear in female Lewis rats As a control, 10 μΐ 
PBS was injected into the left ear After 24 hr the in­
crease in ear thickness was determined using an in­
dustrial micrometer The seventy of ear swelling was 
expressed as the ratio of the thickness in the right ear 
over the left (control) ear The rats were then sacrificed 
to determine the level of inflammation by histology 
Histology 
Knee or ankle joints and ears were removed and pro­
cessed for histology as described (12) Paraffin sections 
(7 μπι) were made and stained with hematoxylin and 
eosin (H&E) Scoring of inflammation was done by two 
independent observers on coded sections 
mAb Treatment 
In all the zymosan-induced inflammation experi­
ments the animals were pretreated for 1 hr before in-
TABLE 1 
Peritoneal Recruitment Assay 
Treatment 
Eipt 1 
Control IgG 
aCDie 
aCDlla 
aCDllb 
Expt 2 
Control IgG 
aCD18 
aCDlla 
aCDllb 
Eipt 3 
Control IgG 
aCDlB 
aCDlla 
aCDllb 
η 
5 
5 
5 
10 
10 
10 
10 
6 
6 
6 
6 
Total cell 
nurober χ 10' 
obtained (тот 
peritoneum 
5 4 * 1 3 
ND 
1 5 ± 0 6* 
1 β ± 0 8* 
10 2 * 2 7 
1 8 * 1 3 * 
6 6 * 2 2 * * 
6 0 * 2 5 * · 
143 ± 2 2 
1 7 ± 0 3* 
8 2 ± 1 3** 
9 1 *. 3 3*· 
Blockade 
— 
72 
63 
82 
35 
41 
88 
43 
36 
Identification 
of peritoneal 
« 1 1 , 
PMN 
ND 
ND 
ND 
6 3 ± 3 
6 6 ± 4 
6 3 ± 3 
6 9 * 4 
ND 
ND 
ND 
ND 
Mo 
37 * 3 
34 * 4 
37 ± 3 
31 ± 4 
Note Effect of mAb pretreatment on leukocyte migration to the 
peritoneum of female (Experiment 1) and male (Experiment 2) Lewie 
rate 1Θ hr after 5 mg zymosan in 2 ml saline In Experiment 3 the 
peritonitis was induced in male Lewie rate with 5 mg zymosan in 4 
ml of saline Blockade of the migration compared to the control IB 
significant *P < 0 001 and **P < 0 02 (Wilcoxon rank sum test) In 
Experiment 2 differential leukocyte counts were performed morpho 
logically using Wright giemsa stained elide preparations The ratio 
of polymorphonuclear (PMN) cells and mononuclear (Mo) cells was 
determined by counting at least 200 nucleated cells ND not done 
Presented are the mean values ± SD (η = number of animals per 
group) The majority of cells in the peritoneum are PMNs 
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ARTHftITIS SCORE 
DAYS 
FIG 1 Effect of intravenous injections of 4 mg of aCD18, 
oCDlla, aCDl lb and IgGl control on the development of AA 
Treatment was performed every other day Blarting at Day 7 after 
immunization The arthritis score is expressed as the вит of both 
hind paws Each group consisted of six animals per group 
auction of the inflammation Furthermore, all mAbs 
were injected into the tail vein at a dose of 2 mg, dis­
solved in 1 ml saline 
Regarding the AA model, each animal was injected 
lv with 4 mg of each mAb (m 1 ml saline) every other 
day, starting at Day 7 after induction of the disease 
FACS Analysis 
In AA the treatment protocol was verified at Day 19 
by collecting heparin blood of each animal for FACS 
analysis This FACS analysis was carried out using 
standard procedures Briefly, 100 μΐ heparin blood of 
each animal was incubated for 30 min at 4°C with ei­
ther the control mAb or with the mAb used for in vivo 
treatment The samples were then washed in PBS-1% 
BSA and 0 1% sodium azide, and labeled at 4°C with 
FITC-conjugated F(ab')2 fragments of rabbit anti-
mouse IgG (Dakopatts, Denmark) After 30 min the 
erythrocytes were lysed and the cells were washed with 
PBS-1% BSA and 0 1% sodium azide Finally 5000 
cells from each sample were analyzed in a Coulter Ep­
ics flow cytometer 
In addition, serum of each animal was collected and 
analyzed for the presence of free mAbs Therefore, 
cytospins of naive peritoneal cells were incubated for 1 
hr with sera from the AA rats, which were injected 
with aCD18, aCDlla, aCDllb, or the control IgGl 
These murine IgGs were then detected with rabbit 
anti-mouse IgG peroxidase (Dakopatts, Denmark) 
RESULTS 
Effect of mAbs m Zymosan-Induced Peritonitis 
We first determined the inhibitory effects of a single 
treatment with 2 mg of either mAb in an acute perito­
nitis Blocking of either CDlla or CDllb appeared to 
be equally effective in inhibiting the influx of inflam­
matory cells (Table 1) In a relatively mild peritonitis, 
inhibition with both mAbs was even more prominent 
(Table 1, Experiment 1) Furthermore, pretreatment 
with the aCD18 mAb, which blocks the common β 
chain of the entire β2 ìntegrin subfamily, almost com-
pletely blocked the influx of inflammatory cells into the 
peritoneum 
Differential leukocyte counts showed that two-thirds 
of the infiltrating cells were PMN cells and one-third 
were mononuclear (Mo) cells No differences were ob-
served in the PMN/Mo ratio between the different 
groups (Experiment 2) 
Since we observed that these mAbs were effective in 
an acute peritonitis, similar dosages were used for 
modulation of joint inflammation 
Effect of mAbs on Development ofAA 
In AA 2 mg of either mAb was injected every other 
day, starting 7 days after induction of disease (6 days 
before the first macroscopic signs) Since no effect was 
TABLE 2 
FACS Analysis on Circulating Phagocytes from Animals Treated with Different Anti-ß2 Integrins during AA 
Origin cells 
Control IgG group 
0CDI8 group 
aCDlla group 
aCDllb group 
Incubated with mAb 
Control IgG 
aCD18 
aCDlla 
aCDllb 
Control IgG 
aCDIB 
Control IgG 
aCDlla 
Control IgG 
aCDllb 
Mean Я 
PMNs 
13 ± 1 
214 г i e 
170 » 11 
124 ± 7 
181 г 13 03%) 
194 ϊ 20 
104 ± 23 (81%) 
128 г 28 
169 ± 14 (97%) 
174 ± 15 
uoreecent intensity and % blockade 
Lymphocytes 
8 : 1 
28 ± 3 
37 i 3 
11 * 1 
17 ± 2 (81%) 
21 ± 3 
15 ± 2(100%) 
15 î 3 
11 ± 2 (92%) 
12 ± 1 
Mononuclear celU 
9 i 1 
540 ΐ 63 
529 ΐ 51 
235 ± 25 
564 ΐ 79 (95%) 
596 ± 54 
488 » 71 (95%) 
512 - 61 
184 i 13 (97%) 
190 î 21 
Note Circulating blood celle from the different groups of animale were incubated with either the control ι so type or the mAb used for in vivo 
treatment and the mean fluorescent intensity was determined on a FACS Each value represents the mean :£ SD of six animals 
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FIG. 2. Histology of rat knee joints 24 hr after 200 μg zymosan ia previously injected with either (a) aCD18 or (b) IgGl control Control 
joint was injected ia with PBS (c>. Staining: hematoxylin & eosin. Original magnification: *23. F, femur; P, patella 
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observed with this protocol (data not ehown), not even 
in the aCD18-treated animals, it was decided to in-
crease the mAb dose to 4 mg However, even treatment 
with the high dose of either mAb did not suppress paw 
swelling in comparison with the control IgGl (Fig 1) 
Moreover, histological analysis of the joints revealed 
no effect at all on the number of infiltrating cells, not 
even in the aCD18-treated animals (data not shown) 
At the end of the experiment, 2 days after the last 
mAb injection, a FACS analysis was performed on the 
circulating leukocytes This was done in order to de-
termine whether sufficient concentrations of either 
mAb had been administered This analysis showed 
that the binding of IgG to the various ß2 integrine on 
the circulating phagocytes was still high and could 
hardly be increased by ex vwo incubation with the 
same mAbs (Table 2) Furthermore, Table 2 shows a 
high fluorescence intensity on PMNs and Mo cells, 
while incubation with a C D l l a and aCD18 only 
showed a low fluorescence intensity on Τ cells In ad­
dition, a two-fold increase was found in the number of 
circulating phagocytes in the aCD18-treated animals, 
a phenomenon which was also observed in CD18-
deficient patients (13) 
Finally, immunocytochemistry showed that free 
mAbs were still present in sera of the different groups 
of animals, since peritoneal cells obtained from un­
treated rats, incubated with these sera, became posi­
tive for the various anti-ß2 integrine (data not shown) 
Altogether these data indicate adequate mAb titers in 
the treated animals 
Effect of mAbs on Locally Induced 
Zymosan Inflammation 
Given the different effects of the anti-ß2 ìntegrin 
mAbs in a peritonitis, as compared with AA, it became 
of interest to investigate the role of the ß2 integrine in 
inflammations at different sites, elicited with the same 
stimulus Zymosan was therefore injected in either the 
joint or derm after the animals were pretreated with 
aCDlla, aCDl lb, or aCDIS Since 2 mg of either mAb 
was sufficient to inhibit the influx of phagocytes to the 
peritoneum, the same dose was used in the joint and 
derm 
In a zymosan-induced joint inflammation, a dose-
dependent increase of infiltrating cells in the control 
mAb-treated animals was observed and consisted pre-
dominantly of PMNs (Fig 2B) As seen in Table 3, 
aCD18 pretreatment blocked the influx of inflamma-
tory cells in both the 0 2- and 0 6-mg zymosan-induced 
inflammation In contrast, with the peritonitis experi-
ments, both aCDlla and aCDllb groups showed no 
decrease in the number of infiltrating cells Remark-
ably, aCDllb pretreatment even caused a minor, but 
not significant, increase in the level of inflammation at 
the highest dose 
Injection of 40 μg of zymosan in the derm of the ear 
induced an inflammation which almost exclusively at­
tracted PMNs (Fig 3B) Both aCD18 and aCDlla were 
able to reduce ear swelling, although aCDlla was less 
prominent (Table 4) aCDllb appeared to have no ef­
fect on the swelling (compared to the control mAb) 
Histological analysis of the H&E-stained sections 
showed that aCD18 pretreatment almost completely 
blocked the influx of PMNs In contrast, treatment 
with aCDlla alone tended to decrease the number of 
infiltrating cells, but this was variable and did not 
reach significance aCDllb pretreatment exhibited no 
effect at the histological level 
DISCUSSION 
Adhesion of inflammatory cells such as lymphocytes, 
granulocytes, and monocytes to the vascular endothe­
lium is essential for transendothehal migration toward 
an inflamed site Several studies have already showed 
that in vivo phagocyte migration to the joint can be 
partially or completely blocked using specific mAbs 
raised against the ß2 integrine or their hgand ICAM-1 
(3-5) 
Our peritonitis data are m agreement with earlier 
findings on anti-ß2 ìntegrin treatment of an inflamed 
peritoneum in mice (14, 15) A single study in the rat 
(10) showed a similar trend, although the net suppres-
sion of cell influx was less impressive In contrast, a 
recent report (16) observed a CDll/CD18-independent 
phase (24 hr) in a rabbit peritonitis model However, 
this etudy used different stimuli (peptone or Escheri-
chia coli) to induce the peritonitis, suggesting that the 
regulation of migration might be stimulus dependent 
In addition, our data clearly indicate that these mAbs 
are effective for investigating the in vivo role of the ß2 
integrine in joint inflammation 
TABLE 3 
Hmtology Scores of Unilateral Zymosan Inflammation 24 
hr after Intraarticular Injection 
Treatment 
lipt 1 
Control IgG 
QCD18 
aCDlla 
aCDllb 
lipt 2 
Control IgG 
aCDIS 
aCDlla 
aCDllb 
Zymosan doee 
(mg) 
0 2 
0 2 
0 2 
0 2 
Об 
0 6 
0 6 
0 6 
Inflammation 
1 8 ± 0 3 
0 7 ± 0 3 · 
1 6 ± 0 7 
1 9 ± 0 5 
2 4 ± 0 3 
1 3 i 0 4* 
2 4 ± 0 4 
2 8 ± 0 2 
Note Histological всогев 24 hr oner zymosan intraarticular Level 
of inflammation was scored on coded, hematoxylin and eosin etained 
elides 0, no inflammation, 3 large mass of inflammation * P < 0 01 
(Wilcoxon rank sum test) Values represent the mean ± SD of six 
animale per group 
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FIG. 3. Histology of rat ears 24 hr after 40 μg zymosan intradermal^, previously injected with either (A) aCD18 or (Bt control isotype 
Control ear was injected with PBS (C). Staining: hematoxylin & eosin. Original magnification: x90. 
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TABLE 4 
R/L Ratios of Ear Thickness and Histology Scores 24 hr 
after Intradermal Zymosan Injection 
Swelling Histological scores 
Treatment R/L rallo $ Inhibition Inflammation Я Blockade 
Control I g G l S 3 ± 0 12 2 3 ± 0 7 
0CDI8 1 45 ± 0 08* 46 0 3 ± 0 2· Θ9 
aCDlla 166 ± 0 0 8 " 20 1 8 * 0 7 22 
oCDllb 1 7 6 ± 0 0 3 8 2 1 ± 0 3 β 
Noti Effect of MAb prelreatment on ear thickness and leukocyte migration 
24 hr after inducing an intradermal inflammation The seventy of ear swelling 
is eipreased as the ratio of the thickness in the nght over that of the left ear 
•P < 0 01 and "P < 0 05 (Wilcoxon rank sum lest) Level of inflammation was 
acorad on coded hematoxylin and eosin stained slides 0 ~ no inflammation 3 
• large masa of inflammation Valuee represent the mean ± SD of en animals 
per group 
Earlier studies demonstrated that the ß2 integrins 
play a role in Ag presentation (17) and cell-cell inter-
actions between antigen-presenting cells and Τ cells (4, 
6) To exclude this type of interference on generation of 
immunity in our adjuvant arthritis studies, we decided 
to start treatment with either mAb 7 days after induc­
tion of AA, at that time point AA can already be trans­
ferred with lymphocytes (1Θ) Our protocol did not pre­
vent AA, suggesting that the dominant migration of 
cells to arthritic joints is at least in part mediated via 
CDlla/CDllb-independent mechanisms This is in 
agreement with recent studies showing that a major 
portion of the PMNs and Τ cells use CDlla/CDllb-
ìndependent mechanisms during AA, aCDlla par-
tially inhibited only the influx of PMNs (7), while 
uVLA-4 (a4ßl) was able to selectively inhibit the in-
flux of Τ cells (19) Furthermore, aICAM-1 treatment 
appeared to have at best minimal effects on the onset of 
AA in an adoptive transfer experiment (6) 
In contrast, studies in other models, e g, insulin-
dependent diabetes mellitus (20) and experimental au­
toimmune uveitis in mice (21) or autoimmune glomer­
ulonephritis in rats (22), showed suppression of disease 
development with early anti-ß2 treatment However, 
since late treatment showed no effects, interference 
with cell-cell interaction and the generation of autore-
active Τ lymphocytes may very well have accounted for 
these protective effects Interestingly, late treatment 
(Day 7) with aCOllb in rat EAE inhibited disease de­
velopment (10) However, histological analysis showed 
no reduction in the number of infiltrating macro­
phages, suggesting that this treatment protocol may 
have influenced other phagocyte functions rather than 
migration Recent reports that otICAM-l mAbs had no 
effect on EAE (23, 24) support the latter 
Our FACS analysis data show that the expression of 
the CDlla and of course CDllb molecules was very 
low on circulating lymphocytes This suggests that the 
influx of Τ cells, which play such an important role in 
AA (1Θ), is not suppressed and that the Τ cell-mediated 
regulation of phagocyte influx uses different integrins 
as compared with nonimmune inflammation Integrins 
like VLA-4 are expressed at higher levels on lympho­
cytes (25) and therefore may form a more promising 
target in inhibiting Τ cell-driven arthritis Interest­
ingly, several in vitro studies show a prominent role for 
VLA-4 in the lymphocyte-rheumatoid synovium inter­
actions (26-28) 
Our results with aCDIS treatment in nonimmune 
inflammation are m agreement with earlier reports on 
aCD18 mAbs in the joint (3, 5) and other acute inflam­
matory models (29-35) Regarding the selective block­
ing of either CDlla or CDllb, variable results have 
been reported Slight inhibitory effects were found with 
aCDlla in the joint (4, 7) and derm (36) Recently, 
Mulligan et al (37) reported that a PMN-dependent 
inflammation could be effectively blocked with 
aCDlla, whereas an inflammation in which macro­
phages were the main effector cells appeared to be more 
CDllb dependent In our zymosan-induced joint and 
dermal inflammation, PMNs were the main infiltrat­
ing cells, yet we did not observe significant suppression 
with aCDlla Pretreatment with aCDllb had no effect 
in a dermal inflammation and even slightly enhanced 
a joint inflammation Interestingly, this latter effect 
has also been reported in a dermal inflammation model 
(36) In that study it was suggested that blocking of 
CDllb may prime or activate phagocytes for a more 
efficient response to C5a 
In conclusion, the relative contribution of the vari­
ous adhesion molecules seems site and stimulus spe­
cific, a phenomenon which has also been observed m 
vitro (38) Our data suggest that inhibition of one ß2 
integnn in the joint and derm is insufficient and might 
even facilitate the usage of other ß2 integrine In the 
peritoneum, influx requires the combined expression of 
CDlla and CDllb since blocking one or the other is 
already sufficient to diminish the influx of PMNs and 
macrophages Whether these differences reflect low ex-
pression of adhesion molecules on pentoneal endothe-
lium per se or local release of different cytokine bal-
ances remains to be investigated Future studies with 
mAbs directed against other integrine (VLA-4, CDllc) 
or combinations of these mAbs should help unravel the 
applicability to block particular joint inflammations 
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CHAPTER 8 
SUMMARY/SAMENVATTING 

SUMMARY AND CONCLUDING REMARKS 
Rheumatoid arthritis (RA) is a chronic and erosive joint inflammation of an 
unknown etiology. To facilitate research on this autoimmune disease, several animal 
models are available, which contribute to the elucidation of the pathogenesis of this joint 
inflammation. Two well studied bacterial arthritis models are the adjuvant arthritis (AA) 
and the streptococcal cell wall-induced arthritis (SCW-induced arthritis). For AA and 
SCW-induced arthritis both polymorph and mononuclear cells as well as Τ cells are 
essential for the development and maintenance of disease. However, the exact 
pathogenesis of these bacterial-induced arthritis models is still unknown. On the one side 
one can think of a specific Τ cell reaction against bacterial fragments, which are present 
in the joint, while on the other hand crossreactivity between bacterial epitopes and 
cartilage may play a role in disease development. Apart from the genetic background and 
the immune system some studies also suggest that the neuroendocrine system may be 
crucial in regulating the susceptibility to bacterial-induced arthritis. Furthermore, there is 
increasing evidence that both the neuroendocrine and immune system are able to 
communicate through overlapping regulatory mediators. 
In this thesis we have studied the regulatory aspects of the immune and 
neuroendocrine system in bacterial arthritis models. First of all we were interested in 
whether crossreactivity had any in vivo relevance in the pathogenesis of these bacterial 
arthritis models. In addition, we wanted to gain more insight in the mechanisms which 
are important in regulating the susceptibility in different rat strains and lines. Finally, we 
investigated several ways to modulate arthritis with selective blocking or elimination of 
the inflammatory cells. 
In the first study we confirm earlier findings, that Τ cells are important in these 
bacterial-induced arthritis models. Treatment with anti-CD4 in a prophylactic protocol 
resulted in virtual absence of SCW-induced arthritis, while on an established disease only 
a minimal suppression was observed. Furthermore, we found that treatment with anti-
CD4 plus SCW induces a long-term resistance to both SCW-induced arthritis and AA. 
This indicates that induction of Τ cell tolerance can be a powerful mechanism to maintain 
prolonged resistance against this type of arthritis (Chapter 2) Recently, clinical trials have 
been started with chimeric monoclonal anti-CD4 antibodies. These studies show that 
treatment with these antibodies were able to decrease the number of circulating Τ cells, 
while no significant adverse effects like e.g. infectious complications were observed. 
Regarding the efficacy of this treatment the data are not unequivocal, but do indicate that 
the type of antibody, the dosage and treatment regimen are crucial factors in determining 
the clinical outcome. 
In SCW-induced arthritis and AA the exact pathogenesis is still unknown. Several 
in vitro studies suggest that cross-reactivity between bacterial epitopes and cartilage may 
be involved in disease development. However, in vivo indications for this hypothesis are 
limited. Sofar, only immuno-modulatory effects of cartilage proteoglycan (PG) fractions 
have been desribed. Therefore, we studied the relevance of the in vitro cross-reactive 
responses against cartilage PG. First, we examined Safranin-0 stained ankle sections, 
and found only minimal PG depletion in both AA and SCW-induced arthritis. These 
histological observations do not fully support the hypothesis that arthritis may be initiated 
by released PG's and structural mimicry between bacterial epitopes and cartilage. 
Interestingly, Τ lymphocytes of these arthritic rats were able to respond to the PG 
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fractions in vitro. In addition, we performed experiments in Lewis rats immunized with 
SCW in freund's incomplete adjuvant (FIA) to generate Τ cell immunity, without 
spontaneous arthritis. In these rats however, we were not able to elicit a joint 
inflammation by an intraarticular injection of papain. Such an injection resulted in the 
release of large amounts of potential cross-reactive cartilage epitopes. These data again 
indicate that cross-reactivity may not play a key role in the initiation of bacterial arthritis. 
However, whether cross-reactivity becomes important at later stages in the disease 
remains to be investigated (Chapter 3). 
In addition, we investigated whether lymphocytes of arthritic donor rats are able to 
specifically migrate to the synovium and subsequently initiate arthritis. Therefore, we 
performed adoptive transfer experiments with fluorescent Τ cells obtained from rats with 
AA, and determined the distibution of these transferred cells in various types of tissue 
(Chapter 4). If cross-reactivity between bacterial epitopes and cartilage may be involved 
in the initiation of bacterial-induced arthritis, then one would expect that these bacterial-
specific Τ cells would migrate to the synovium, proliferate in response to cartilage 
proteoglycans, and initiate arthritis. Interestingly however, we were not able to detect any 
labelled cells in the joint, suggesting that the cellular infiltrate at the lesion site is mainly 
host derived. To support these findings further, we performed adoptive transfer 
experiments to nude Lewis rats, which are reported to lack almost all mature Τ 
lymphocytes. These recipients only developed a mild and non-progressive arthritis, which 
supports the conclusion that a host-derived T-cell population is essential for the 
development of arthritis by adoptive transfer. Furthermore, these data further indicate that 
cross-reactivity is not a likely mechanism for the initiation of bacterial arthritis. 
Besides the pathogenesis of bacterial-induced arthritis, it was still not completely 
understood why the Lewis strain is susceptibile and the histocompatible F344 (Fisher) 
resistant. In this respect, we have earlier described that the F344 strain shows Τ cell 
unresponsiveness to SCW and explained the underlying mechanism as immunological 
tolerance. On the other hand, the susceptibility of the Lewis strain was explained by 
others as a defect in the hypothalamic-pituitary-adrenal (ΗΡΑ) axis, leading to an 
impaired corticosterone responsiveness. We further examined the potential mechanisms 
which may explain the resistance of F344 rat. It was found that the F344 strain can 
become susceptible for AA, using a more powerful adjuvant. This indicates that the F344 
rat does not lack Τ effector cells and that neither clonal deletion nor clonal anergy can 
explain its resistance. Next it was tested, whether the ΗΡΑ activity was the responsible 
mechanism for suppression. However, we found identical levels of corticosterone after 
IL-la injection in both the resistant F344 and susceptible GF F344. This suggests that 
corticosterone is not the most important mechanism to suppress disease development in 
these animals. Finally, we investigated whether active suppression may be responsible for 
regulating the resistance. This was performed by pretreating the animals with the 
immunomodulatory drugs cyclophosphamide and cyclosporin A. Our treatment protocol 
did not make the F344 rat susceptible, indicating that active suppression does not play a 
role in the induction phase of arthritis. Probably the F344 rat needs to upregulate 
suppression/tolerance upon bacterial challenge (Chapter 5). 
In chapter 6 we further investigated the importance of both the neuroendocrine 
(ΗΡΑ axis) and immune system in determining the susceptibility. We observed that the 
stress-susceptible Wistar rat line (APO-SUS) was completely resistant for AA, while the 
stress-resistant Wistar rat line (APO-UNSUS) appeared to be moderately susceptible. This 
indicates that different types of behavioural and neuroendocrinological responses to stress 
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are correlated to different susceptibility to AA. Furthermore, the germ-free (GF) Wistars 
were highly susceptible to AA, indicating that the bacterial ñora is of prime importance to 
prevent arthritis. Next it was examined, whether the observed difference in susceptibility 
was determined by the ΗΡΑ-axis activity. Therefore, corticosterone levels were analysed 
in response to IL-la in APO-SUS and APO-UNSUS Wistar lines and in GF and 
conventional (CV) rat strains. The data show that the ΗΡΑ axis activity did not determine 
the susceptibility to AA. In addition, we measured plasma corticosterone levels around 
the onset of AA in both GF and CV F344 rats. Whereas no rise was seen in the arthritis-
resistant CV rats, a significant increase was observed in the arthritis susceptible GF rats. 
This suggests that the ΗΡΑ axis activity is a determinant in modulation of disease 
activity, rather than being a mechanism to prevent disease. 
Finally, in chapter 7 we examined the role of the B2 integrins in the recruitment of 
phagocytic cells in joint inflammation. These adhesion molecules appear to be involved in 
the adhesion and transendothelial migration of phagocytes to the inflammatory site. The 
B2 subfamily of integrins comprises 3 members of adhesion molecules: CDlla/CD18, 
CDllb/CD18 and CDllc/CD18, which are expressed on monocytes and granulocytes. In 
addition, CDlla/CD18 is also expressed on В and Τ lymphocytes, although at a low 
level. We found that selective blocking of the phagocytic cell influx with antibodies 
directed against the ß2 subfamily was not effective in suppressing AA. Moreover, we 
examined the same antibodies in an acute non Τ cell mediated inflammation at different 
sites in the rat. For this purpose zymosan was injected in either the joint, peritoneum or 
derm. We observed that pretreatment with aCDlla or aCDllb could only inhibit the 
influx of phagocytes to an inflamed peritoneum, but not towards an inflamed joint or 
dermal inflammation. In contrast, treatment with aCD18 was able to block effectively, 
independent of the site of inflammation. These data indicate that the relative contribution 
of the individual ß2 integrins seems site and stimulus specific. Interestingly, a recent 
report showed prevention of the onset of AA with a single injection of antibodies directed 
against VLA-4 (ßl integrin). This suggests, that therapy aimed at other adhesion 
molecules like VLA-4, may give promising results in discrete blocking of the leukocyte 
influx in particular joint inflammations. 
In conclusion, Τ cells play a pivotal role in the bacterial-induced arthritis models 
discussed above and Τ cell tolerance generated and maintained by the bacterial flora is an 
important mechanism to regulate the susceptibility. However, whether in vivo 
crossreactivity plays a role in the pathogenesis of these models remains to be further 
investigated. 
Finally, an always returning question is of course the relevance of these bacterial-
induced arthritis models. In the last few years several studies have investigated the effects 
of antibodies directed against the cytokines interleukin-1 (IL-1) and tumor necrosis factor­
es (TNF-α) in various arthritis models. For instance, we found that treatment with anti-IL-
1 in an established collagen induced arthritis resulted in an amelioration of both 
inflammation and cartilage destruction, while less effect was observed in the anti-TNF 
treated animals. On the other hand, when we examined the effects of the same antibodies 
in an unilateral arthritis, induced by bacterial fragments, we observed exactly the opposite 
effect. This time anti-TNF treatment was able to signifcantly suppress the level of 
inflammation, while anti-IL-1 appeared to have a minor effect. In addition to this, studies 
have been initiated to examine the effects of anti-TNF treatment in rheumatoid arthritis 
and the first data show significant clinical and laboratory improvements. The findings 
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indicate that TNF is not only an important regulator in an unilateral arthritis model 
induced by bacterial fragments, but also in RA. This suggests some similarity in the 
pathogenesis. Therefore, it not only remains relevant to perform research in various 
arthritis models, but also points towards a role of bacteria in the pathogenesis of 
rheumatoid arthritis. 
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SAMENVATTING 
Reumatoïde arthritis (RA) is een chronische vorm van gewrichtsontsteking die bij 
ongeveer 2% van de volwassen bevolking voorkomt. Het is een systemische ziekte, wat 
inhoudt dat naast de gewrichten ook andere weefsels zoals bijv. bloedvaten, hart en 
longen aangedaan kunnen zijn. Tot nu toe is de oorzaak van RA onbekend, maar er zijn 
aanwijzingen, dat bacteriën een rol spelen bij de inductie van arthritis. Zo is er een relatie 
gevonden tussen bacteriële infecties en arthritis. Bekende humane voorbeelden hiervan 
zijn de reactieve arthritis en de verhoogde associatie van arthritis met de ziekte van Crohn 
en jejunum bypass operaties. Daarnaast is het ook mogelijk om in ratten arthritis op te 
wekken d.m.v. bacteriën. De twee bekendste voorbeelden hiervan zijn adjuvant arthritis, 
wat geïnduceerd kan worden door het subcutaan inspuiten van kleine hoeveelheden 
Mycobacterium in olie, en het Streptococcen celwanden-geïnduceerde arthritis model, 
waarbij grote hoeveelheden celwand-fragmenten van Streptococcus Pyogenes 
intraperitoneaal worden ingespoten. Met behulp van deze experimentele diermodellen kan 
men inzicht verkrijgen in de ontstaanswijze van chronische gewrichtsontstekingen en 
nieuwe therapieën uittesten. 
Zowel bij adjuvant arthritis als bij Streptococcen celwanden-geïnduceerde arthritis 
zijn mononucléaire phagocyten (monocyten en macrofagen) en Τ cellen van essentieel 
belang. Mogelijke mechanismen die deze chronische arthritis modellen kunnen verklaren 
berusten enerzijds op een specifieke Τ cel reactie tegen bacterieel materiaal, wat zich in 
de gewrichten bevindt, anderzijds op inductie van kruisreactiviteit tegen proteoglycanen 
van het gewrichtskraakbeen. Immers, bacteriën en proteoglycanen vertonen structureel 
enige overeenkomsten. 
Betreffende de gevoeligheid voor deze vorm van arthritis, is niet alleen de 
genetische achtergrond bepalend, maar schijnt er ook een regulerende rol weggelegd te 
zijn voor de bacteriële flora. Zo is de Lewis rat gevoelig, de vrijwel genetisch identieke 
Fisher ongevoelig en de kiemvrije Fisher weer wel gevoelig voor bacteriële arthritis. 
Daarnaast suggereren een aantal andere studies, dat ook het neuroendocriene systeem een 
regulerende rol heeft in de gevoeligheid. Daarbij moet men niet uit het oog verliezen, dat 
het neuroendocriene en het immuun systeem goed met elkaar kunnen communiceren door 
middel van overlappende regulatoire mediatoren. 
In de eerste studie (hoofdstuk 2) bewijzen we de cruciale rol van Τ cellen in 
Streptococcen arthritis. Eliminatie van de Τ cellen m.b.v. antilichamen gericht tegen de 
CD4 moleculen ten tijde van arthritis inductie, resulteerde in een langdurige resistentie. 
Zelfs als in een later stadium deze Τ cellen weer op een normaal niveau waren gekomen, 
bleken deze proefdieren nog steeds resistent tegen de inductie van bacteriële arthritis. 
Vervolgens probeerden we meer inzicht te verkrijgen in het ontstaan van deze 
vorm van gewrichtsonsteking. Een mogelijke hypothese is kruisreactiviteit tussen 
bacteriële epitopen en kraakbeen. Zo zijn er een aantal in vitro studies, die dit soort 
kruisreagerende Τ cel responsen aantonen. Echter, in vivo bevindingen, die de relevantie 
van kruisreactiviteit onderbouwen zijn zeer beperkt en deze hypothese is nader getoetst. 
Zo konden wij in hoofstuk 3 inderdaad in vitro kruisreacties van Τ cellen aantonen, maar 
bij analyse van de ontstoken gewrichten bleek het kraakbeen slechts minimaal beschadigd 
te zijn. Deze bevindingen duiden erop dat kruisreactiviteit waarschijnlijk minder 
belangrijk is in het ontstaan van bacteriële arthritis. Deze conclusie werd vervolgens 
indirect onderbouwd door de proeven, waarbij de ziekte passief werd overgebracht d.m.v. 
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Τ cellen (hoofdstuk 4). Immers, wanneer wij arthritogene Τ cellen merken met een 
fluorescerend label en inspuiten in gezonde ontvanger dieren, konden wij geen 
accumulatie van deze fluorescerende Τ cellen in de gewrichten aantonen. Dit zou je niet 
verwachten, wanneer kruisreactiviteit een rol speelt bij arthritis inductie. Tevens 
suggereert het, dat de ontstekingscellen (T cellen) in het gewricht voornamelijk afkomstig 
zijn van de ontvanger zelf. Deze conclusie wordt gesteund door proeven, waarbij de 
ziekte passief werd overgebracht naar naakte ontvanger dieren. Deze ratten missen 
functionele Τ cellen in hun immuun systeem en bleken slechts matig gevoelig te zijn voor 
deze vorm van arthritis inductie. Alhoewel de combinatie van deze bevindingen het 
belang van kruisreactiviteit in dit model in twijfel trekt, kunnen we niet uitsluiten dat 
kruisreactiviteit een rol gaat spelen in latere stadia van ontsteking. 
Los van het feit, dat het mechanisme leidend tot gewrichtsontsteking in adjuvant 
arthritis nog onbekend is, is het ook nog steeds niet duidelijk, waarom de Lewis rat 
gevoelig is voor bacteriële arthritis, de genetisch identieke Fisher rat ongevoelig en de 
kiemvrije Fisher rat weer wel gevoelig. Om hier meer duidelijkheid in te krijgen, werden 
in hoofdstuk 5 een aantal potentiële mechanismen onderzocht, die de ongevoeligheid van 
de Fisher rat zouden kunnen verklaren. Zo vonden we in deze studie, dat de Fisher ratten 
geen Τ effector cellen missen, want ze konden wel een arthritis krijgen, wanneer we een 
krachtiger adjuvant gebruikten. Vervolgens toonden we aan, dat na injectie van het 
ontstekingsbevorderend eiwit interleukine-1 (IL-1) er geen verschil was in de endogene 
produktie van corticosteron in de ongevoelige Fisher en de gevoelige kiemvrije Fisher. 
Deze bevindingen suggereren, dat niet alleen een hoge activiteit van de hypothalamus-
hypophyse-bijnier (HHB) as (het neuroendocrine system) verantwoordelijk kan zijn voor 
de ongevoeligheid van de Fisher rat. Tenslotte vonden we, dat de F344 rat ongevoelig 
bleef voor arthritis na voorbehandeling met immunosuppressieve middelen, wat erop duidt 
dat actieve suppressie geen rol speelt in de inductie fase van de arthritis. Een voorlopige 
conclusie is, dat de Fisher rat zijn suppressie/tolerantie mechanisme pas activeert bij 
hernieuwd contact met bacteriën. 
In hoofdstuk 6 onderzochten we niet alleen het belang van de bacteriële flora, 
maar ook of een verschillend type gedrag op stressvolle omstandigheden de gevoeligheid 
voor bacteriële arthritis kan bepalen. Zo vonden we, dat de stress-gevoelige Wistar 
rattelijn (APO-SUS) totaal ongevoelig was voor adjuvant arthritis, terwijl de stress-
ongevoelige Wistar rattelijn (APO-UNSUS) matig gevoelig bleek te zijn. Dit betekent, dat 
verschillend gedrag en neuroendocrinologische responsen op stress correleren met een 
verschillende gevoeligheid voor arthritis. Daarnaast vonden we in deze studie, dat de 
kiemvrije Wistar ratten zeer gevoelig bleken te zijn voor arthritis. Deze bevindingen 
duiden erop, dat de bacteriële flora uitermate belangrijk is voor het voorkómen van 
arthritis. Tenslotte bestudeerden we, of deze verschillen in gevoeligheid verklaard konden 
worden door een verschil in de aktiviteit van de HHB-as. Echter de resultaten laten zien 
dat de aktiviteit van de HHB-as meer een regulerende rol vervuld in de emst van de 
ontsteking, dan een mechanisme is om de arthritis te voorkomen. 
Uiteindelijk onderzochten in hoofdstuk 7 de rol van de &2 integrinen in het 
rekruteren van ontstekingscellen tijdens arthritis. Immers, wanneer ontstekingscellen naar 
een ontstekingsgebied migreren, maken deze cellen gebruik van adhesiemolekulen om via 
de bloedvaatwand de bloedbaan te kunnen verlaten. De &2 subfamilie van integrinen 
bestaat uit 3 verschillende type adhesie moleculen: CDlla/CD18, CDllb/CD18 en 
CDllc/CD18, welke zich bevinden op zowel monocyten als macrofagen. Bovendien 
bevindt CDlla/CD18 zich ook nog op В en Τ cellen, alhoewel op een laag niveau. Deze 
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Studie laat zien, dat het blokkeren van de influx van phagocyten m.b.v. antilichamen 
gericht tegen de B2 subfamilie (aCDlla, aCDllb en aCD18) geen effect had op het 
onderdrukken van adjuvant arthritis. Daarnaast onderzochten we ook de effecten van 
dezelfde antilichamen in een acute niet Τ cel gemedieerde ontsteking op verschillende 
plaatsen in de rat. Deze experimenten laten zien, dat voorbehandeling met aCDlla of 
aCDllb alleen de influx van phagocyten naar een ontstoken buikholte konden blokkeren, 
terwijl we geen effect zagen in een ontstoken gewricht of huidontsteking. Daarentegen, 
bleek aCD18 voorbehandeling zeer effectief te zijn, onafhankelijk van de plaats van de 
ontsteking. Dit suggereert, dat de relatieve bijdrage van de individuele ß2 integrinen 
plaats en stimulus afhankelijk is. 
Concluderend, Τ cellen spelen een onmisbare rol in bacterieel geïnduceerde 
arthritis modellen. Daarnaast is Τ cel tolerantie, opgebouwd en onderhouden door de 
bacteriële flora, een uitermate belangrijk mechanisme om de gevoeligheid voor arthritis te 
bepalen en schijnt neuroendocrine regulatie minder essentieel. Tenslotte, lijkt het 
onwaarschijnlijk, dat kruisreactiviteit met kraakbeen een belangrijke rol speelt bij het 
ontstaan van bacteriële arthritis. 
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STELLINGEN 
behorende bij het proefschrift 
"Regulation of bacterial induced arthritis". 
1. T-cel tolerantie, opgebouwd en onderhouden door de bacteriële flora, is een 
uitermate belangrijk mechanisme om de gevoeligheid voor arthritis te bepalen. 
Dit proefschrift 
2. Bij het ontstaan van bacteriële arthritis lijkt het onwaarschijnlijk dat kruisreactivi-
teit met kraakbeen een belangrijke rol speelt. 
Dit proefschrift 
3. Bij de keuze van radionucliden voor radioimmunotherapie zal de veiligheid van het 
betrokken medisch personeel een steeds belangrijkere rol gaan spelen. 
Martijn Gerretsen, Proefschrift 1993, Vrije Universiteit Amsterdam 
4. Lever macrofragen kunnen proliferen. 
Rein Hoedemakers, Proefschrift 1993, Universiteit Groningen 
5. Het feit dat de SCW-arthritis gebruik maakt van dode bacteriën is een prettige 
bijkomstigheid, nu blijkt dat Streptococcus pyogenes ook vleesetende capaciteiten 
blijkt te bezitten. 
6. De anti-rookcampagnes houden te weinig rekening met het feit, dat nicotine ook 
heilzame effecten kan uitoefenen, zoals het vertragen of voorkómen van ziekten als 
Parkinson en Alzheimer. 
7. Het is de vraag wie het meeste voordeel heeft van een promotie-onderzoek: de 
promotor of de promovendus. 
8. Het gebruik van afkortingen binnen de pharmaceutische industrie neemt zulke 
vormen aan, dat deze wellicht binnenkort in boekvorm kunnen worden uitgegeven. 
9. Het is goed dat Nederland niet Italië is, anders zou Joop van den Ende nu premier 
zijn. 
10. Het werken met naakte ratten is een schamele troost voor kalende wetenschappers. 
Nijmegen, 9 november 1994 Lex van de Langerijt 



